Results for untargeted MS search on m/z: (+/-) mode
Details | Name | m/z | RT | RT_Units | Study | Ion_mode | MS_Instrument | Chromatography | Species | Source |
---|---|---|---|---|---|---|---|---|---|---|
AN000080 | 1-Aminocyclopropane-1-carboxylicacid | 0.64 | Minutes | ST000047 | POSITIVE | Agilent 6220 TOF | Reversed phase | Human | Cerebrospinal fluid | |
AN000080 | Urea | 0.64 | Minutes | ST000047 | POSITIVE | Agilent 6220 TOF | Reversed phase | Human | Cerebrospinal fluid | |
AN000080 | 2-Hydroxyadipicacid | 0.66 | Minutes | ST000047 | POSITIVE | Agilent 6220 TOF | Reversed phase | Human | Cerebrospinal fluid | |
AN000080 | Purine | 0.67 | Minutes | ST000047 | POSITIVE | Agilent 6220 TOF | Reversed phase | Human | Cerebrospinal fluid | |
AN000080 | (E)-2-Methylglutaconicacid | 0.67 | Minutes | ST000047 | POSITIVE | Agilent 6220 TOF | Reversed phase | Human | Cerebrospinal fluid | |
AN000080 | Niacinamide | 0.67 | Minutes | ST000047 | POSITIVE | Agilent 6220 TOF | Reversed phase | Human | Cerebrospinal fluid | |
AN000080 | Urea+0.6992776 | 0.7 | Minutes | ST000047 | POSITIVE | Agilent 6220 TOF | Reversed phase | Human | Cerebrospinal fluid | |
AN000080 | Urea+0.72563285 | 0.73 | Minutes | ST000047 | POSITIVE | Agilent 6220 TOF | Reversed phase | Human | Cerebrospinal fluid | |
AN000080 | Spermidine | 0.75 | Minutes | ST000047 | POSITIVE | Agilent 6220 TOF | Reversed phase | Human | Cerebrospinal fluid | |
AN000080 | Spermidine+0.7562499 | 0.76 | Minutes | ST000047 | POSITIVE | Agilent 6220 TOF | Reversed phase | Human | Cerebrospinal fluid | |
AN000080 | Purine+0.7625763 | 0.76 | Minutes | ST000047 | POSITIVE | Agilent 6220 TOF | Reversed phase | Human | Cerebrospinal fluid | |
AN000080 | Oxaloglutarate | 0.77 | Minutes | ST000047 | POSITIVE | Agilent 6220 TOF | Reversed phase | Human | Cerebrospinal fluid | |
AN000080 | Urocanicacid | 0.78 | Minutes | ST000047 | POSITIVE | Agilent 6220 TOF | Reversed phase | Human | Cerebrospinal fluid | |
AN000080 | L-Cysteinesulfonicacid | 0.78 | Minutes | ST000047 | POSITIVE | Agilent 6220 TOF | Reversed phase | Human | Cerebrospinal fluid | |
AN000080 | 3,5-dichlorosalicylicacid | 0.78 | Minutes | ST000047 | POSITIVE | Agilent 6220 TOF | Reversed phase | Human | Cerebrospinal fluid | |
AN000080 | 2,4-DICHLOROPHENOXYACETICACID | 0.78 | Minutes | ST000047 | POSITIVE | Agilent 6220 TOF | Reversed phase | Human | Cerebrospinal fluid | |
AN000080 | Dimercaprol | 0.78 | Minutes | ST000047 | POSITIVE | Agilent 6220 TOF | Reversed phase | Human | Cerebrospinal fluid | |
AN000080 | 3,4-dihydroxymandelate | 0.78 | Minutes | ST000047 | POSITIVE | Agilent 6220 TOF | Reversed phase | Human | Cerebrospinal fluid | |
AN000080 | METHYLTHIOURACIL | 0.79 | Minutes | ST000047 | POSITIVE | Agilent 6220 TOF | Reversed phase | Human | Cerebrospinal fluid | |
AN000080 | Vigabatrin | 0.79 | Minutes | ST000047 | POSITIVE | Agilent 6220 TOF | Reversed phase | Human | Cerebrospinal fluid | |
AN000080 | Lysine | 0.8 | Minutes | ST000047 | POSITIVE | Agilent 6220 TOF | Reversed phase | Human | Cerebrospinal fluid | |
AN000080 | Chloralhydrate | 0.82 | Minutes | ST000047 | POSITIVE | Agilent 6220 TOF | Reversed phase | Human | Cerebrospinal fluid | |
AN000080 | GPEtn(O-18:0/22:0)[U] | 0.83 | Minutes | ST000047 | POSITIVE | Agilent 6220 TOF | Reversed phase | Human | Cerebrospinal fluid | |
AN000080 | 22:1Cholesterylester | 0.83 | Minutes | ST000047 | POSITIVE | Agilent 6220 TOF | Reversed phase | Human | Cerebrospinal fluid | |
AN000080 | 1-nonadecanoyl-2-(10Z,13Z,16Z-docosatrienoyl)-sn-glycerol | 0.84 | Minutes | ST000047 | POSITIVE | Agilent 6220 TOF | Reversed phase | Human | Cerebrospinal fluid | |
AN000080 | Glucosylceramide(d18:1/20:0) | 0.84 | Minutes | ST000047 | POSITIVE | Agilent 6220 TOF | Reversed phase | Human | Cerebrospinal fluid | |
AN000080 | C18-Cerebroside | 0.84 | Minutes | ST000047 | POSITIVE | Agilent 6220 TOF | Reversed phase | Human | Cerebrospinal fluid | |
AN000080 | Histidine | 0.84 | Minutes | ST000047 | POSITIVE | Agilent 6220 TOF | Reversed phase | Human | Cerebrospinal fluid | |
AN000080 | GPP(18:1(9Z)/18:1(9Z)) | 0.84 | Minutes | ST000047 | POSITIVE | Agilent 6220 TOF | Reversed phase | Human | Cerebrospinal fluid | |
AN000080 | Cer(d18:0/22:0) | 0.84 | Minutes | ST000047 | POSITIVE | Agilent 6220 TOF | Reversed phase | Human | Cerebrospinal fluid | |
AN000080 | C16Sulfatide | 0.84 | Minutes | ST000047 | POSITIVE | Agilent 6220 TOF | Reversed phase | Human | Cerebrospinal fluid | |
AN000080 | GPEtn(22:6(4Z,7Z,10Z,13Z,16Z,19Z)/20:4(5Z,8Z,11Z,14Z))[U] | 0.84 | Minutes | ST000047 | POSITIVE | Agilent 6220 TOF | Reversed phase | Human | Cerebrospinal fluid | |
AN000080 | 1-eicosanoyl-2-(5Z,8Z,11Z,14Z,17Z-eicosapentaenoyl)-sn-glycerol | 0.84 | Minutes | ST000047 | POSITIVE | Agilent 6220 TOF | Reversed phase | Human | Cerebrospinal fluid | |
AN000080 | GPEtn(18:1(11Z)/18:1(9Z))[U] | 0.84 | Minutes | ST000047 | POSITIVE | Agilent 6220 TOF | Reversed phase | Human | Cerebrospinal fluid | |
AN000080 | 7,8-Diaminononanoate | 0.85 | Minutes | ST000047 | POSITIVE | Agilent 6220 TOF | Reversed phase | Human | Cerebrospinal fluid | |
AN000080 | Vanillacticacid | 0.85 | Minutes | ST000047 | POSITIVE | Agilent 6220 TOF | Reversed phase | Human | Cerebrospinal fluid | |
AN000080 | Diflunisalacylglucuronide | 0.85 | Minutes | ST000047 | POSITIVE | Agilent 6220 TOF | Reversed phase | Human | Cerebrospinal fluid | |
AN000080 | Mebeverinemetabolite(Veratricacidglucuronide) | 0.85 | Minutes | ST000047 | POSITIVE | Agilent 6220 TOF | Reversed phase | Human | Cerebrospinal fluid | |
AN000080 | 3-Aminopropanal | 0.86 | Minutes | ST000047 | POSITIVE | Agilent 6220 TOF | Reversed phase | Human | Cerebrospinal fluid | |
AN000080 | Proline | 0.86 | Minutes | ST000047 | POSITIVE | Agilent 6220 TOF | Reversed phase | Human | Cerebrospinal fluid | |
AN000080 | Loroxanthinester/Loroxanthindodecenoate | 0.86 | Minutes | ST000047 | POSITIVE | Agilent 6220 TOF | Reversed phase | Human | Cerebrospinal fluid | |
AN000080 | CDP-DG(12:0/12:0) | 0.86 | Minutes | ST000047 | POSITIVE | Agilent 6220 TOF | Reversed phase | Human | Cerebrospinal fluid | |
AN000080 | Proline+0.86503255 | 0.87 | Minutes | ST000047 | POSITIVE | Agilent 6220 TOF | Reversed phase | Human | Cerebrospinal fluid | |
AN000080 | Histidine+0.8661965 | 0.87 | Minutes | ST000047 | POSITIVE | Agilent 6220 TOF | Reversed phase | Human | Cerebrospinal fluid | |
AN000080 | 7,8-Diaminononanoate+0.86831826 | 0.87 | Minutes | ST000047 | POSITIVE | Agilent 6220 TOF | Reversed phase | Human | Cerebrospinal fluid | |
AN000080 | Arginine | 0.88 | Minutes | ST000047 | POSITIVE | Agilent 6220 TOF | Reversed phase | Human | Cerebrospinal fluid | |
AN000080 | Pyroglutamicacid | 0.88 | Minutes | ST000047 | POSITIVE | Agilent 6220 TOF | Reversed phase | Human | Cerebrospinal fluid | |
AN000080 | N(pai)-Methyl-L-histidine | 0.88 | Minutes | ST000047 | POSITIVE | Agilent 6220 TOF | Reversed phase | Human | Cerebrospinal fluid | |
AN000080 | Ne-Methyl-L-lysine | 0.88 | Minutes | ST000047 | POSITIVE | Agilent 6220 TOF | Reversed phase | Human | Cerebrospinal fluid | |
AN000080 | beta-Alanine | 0.88 | Minutes | ST000047 | POSITIVE | Agilent 6220 TOF | Reversed phase | Human | Cerebrospinal fluid | |
AN000080 | Citrullinen-butylester | 0.88 | Minutes | ST000047 | POSITIVE | Agilent 6220 TOF | Reversed phase | Human | Cerebrospinal fluid | |
AN000080 | Delphinidin | 0.89 | Minutes | ST000047 | POSITIVE | Agilent 6220 TOF | Reversed phase | Human | Cerebrospinal fluid | |
AN000080 | N-Fluorenylacetamide | 0.89 | Minutes | ST000047 | POSITIVE | Agilent 6220 TOF | Reversed phase | Human | Cerebrospinal fluid | |
AN000080 | LysVal | 0.89 | Minutes | ST000047 | POSITIVE | Agilent 6220 TOF | Reversed phase | Human | Cerebrospinal fluid | |
AN000080 | 16,16-dimethyl-PGF2beta | 0.89 | Minutes | ST000047 | POSITIVE | Agilent 6220 TOF | Reversed phase | Human | Cerebrospinal fluid | |
AN000080 | L-gamma-Cyano-gamma-aminobutyricacid+0.890694 | 0.89 | Minutes | ST000047 | POSITIVE | Agilent 6220 TOF | Reversed phase | Human | Cerebrospinal fluid | |
AN000080 | (E)-2-Methylglutaconicacid+0.8921491 | 0.89 | Minutes | ST000047 | POSITIVE | Agilent 6220 TOF | Reversed phase | Human | Cerebrospinal fluid | |
AN000080 | 3-(a-Naphthoxy)lacticacidglucuronide | 0.9 | Minutes | ST000047 | POSITIVE | Agilent 6220 TOF | Reversed phase | Human | Cerebrospinal fluid | |
AN000080 | TyrCysThr | 0.9 | Minutes | ST000047 | POSITIVE | Agilent 6220 TOF | Reversed phase | Human | Cerebrospinal fluid | |
AN000080 | Shikimicacid | 0.9 | Minutes | ST000047 | POSITIVE | Agilent 6220 TOF | Reversed phase | Human | Cerebrospinal fluid | |
AN000080 | CARBADOX | 0.9 | Minutes | ST000047 | POSITIVE | Agilent 6220 TOF | Reversed phase | Human | Cerebrospinal fluid | |
AN000080 | clavirinI | 0.9 | Minutes | ST000047 | POSITIVE | Agilent 6220 TOF | Reversed phase | Human | Cerebrospinal fluid | |
AN000080 | Quinone | 0.9 | Minutes | ST000047 | POSITIVE | Agilent 6220 TOF | Reversed phase | Human | Cerebrospinal fluid | |
AN000080 | Desethylchloroquine | 0.9 | Minutes | ST000047 | POSITIVE | Agilent 6220 TOF | Reversed phase | Human | Cerebrospinal fluid | |
AN000080 | Ethylenediamine-N,N'-di-a-butyricacid | 0.9 | Minutes | ST000047 | POSITIVE | Agilent 6220 TOF | Reversed phase | Human | Cerebrospinal fluid | |
AN000080 | 2-Amino-3-methyl-1-butanol | 0.9 | Minutes | ST000047 | POSITIVE | Agilent 6220 TOF | Reversed phase | Human | Cerebrospinal fluid | |
AN000080 | Valine | 0.9 | Minutes | ST000047 | POSITIVE | Agilent 6220 TOF | Reversed phase | Human | Cerebrospinal fluid | |
AN000080 | Diacetyl | 0.91 | Minutes | ST000047 | POSITIVE | Agilent 6220 TOF | Reversed phase | Human | Cerebrospinal fluid | |
AN000080 | Hydroxyhydroquinone | 0.91 | Minutes | ST000047 | POSITIVE | Agilent 6220 TOF | Reversed phase | Human | Cerebrospinal fluid | |
AN000080 | Mannitol | 0.91 | Minutes | ST000047 | POSITIVE | Agilent 6220 TOF | Reversed phase | Human | Cerebrospinal fluid | |
AN000080 | 2-Methylbutyrylglycine+0.9057921 | 0.91 | Minutes | ST000047 | POSITIVE | Agilent 6220 TOF | Reversed phase | Human | Cerebrospinal fluid | |
AN000080 | MY-5445 | 0.91 | Minutes | ST000047 | POSITIVE | Agilent 6220 TOF | Reversed phase | Human | Cerebrospinal fluid | |
AN000080 | 2-Hydroxyadipicacid+0.9071934 | 0.91 | Minutes | ST000047 | POSITIVE | Agilent 6220 TOF | Reversed phase | Human | Cerebrospinal fluid | |
AN000080 | Methylphenidate | 0.91 | Minutes | ST000047 | POSITIVE | Agilent 6220 TOF | Reversed phase | Human | Cerebrospinal fluid | |
AN000080 | 2-Oxovalericacid | 0.91 | Minutes | ST000047 | POSITIVE | Agilent 6220 TOF | Reversed phase | Human | Cerebrospinal fluid | |
AN000080 | Triparanol | 0.91 | Minutes | ST000047 | POSITIVE | Agilent 6220 TOF | Reversed phase | Human | Cerebrospinal fluid | |
AN000080 | beta-vinylacrylicacid | 0.91 | Minutes | ST000047 | POSITIVE | Agilent 6220 TOF | Reversed phase | Human | Cerebrospinal fluid | |
AN000080 | HisVal | 0.91 | Minutes | ST000047 | POSITIVE | Agilent 6220 TOF | Reversed phase | Human | Cerebrospinal fluid | |
AN000080 | 3-oxo-4-pentenoicacid | 0.91 | Minutes | ST000047 | POSITIVE | Agilent 6220 TOF | Reversed phase | Human | Cerebrospinal fluid | |
AN000080 | PISCIDICACID | 0.91 | Minutes | ST000047 | POSITIVE | Agilent 6220 TOF | Reversed phase | Human | Cerebrospinal fluid | |
AN000080 | L-arabitol | 0.91 | Minutes | ST000047 | POSITIVE | Agilent 6220 TOF | Reversed phase | Human | Cerebrospinal fluid | |
AN000080 | Urea+0.91156 | 0.91 | Minutes | ST000047 | POSITIVE | Agilent 6220 TOF | Reversed phase | Human | Cerebrospinal fluid | |
AN000080 | Methylglyoxal | 0.91 | Minutes | ST000047 | POSITIVE | Agilent 6220 TOF | Reversed phase | Human | Cerebrospinal fluid | |
AN000080 | PISCIDICACID+0.9124123 | 0.91 | Minutes | ST000047 | POSITIVE | Agilent 6220 TOF | Reversed phase | Human | Cerebrospinal fluid | |
AN000080 | N-Acetyl-a-neuraminicacid | 0.92 | Minutes | ST000047 | POSITIVE | Agilent 6220 TOF | Reversed phase | Human | Cerebrospinal fluid | |
AN000080 | 2-Heptenedioicacid,4-oxo- | 0.92 | Minutes | ST000047 | POSITIVE | Agilent 6220 TOF | Reversed phase | Human | Cerebrospinal fluid | |
AN000080 | N1-Acetylspermidine | 0.92 | Minutes | ST000047 | POSITIVE | Agilent 6220 TOF | Reversed phase | Human | Cerebrospinal fluid | |
AN000080 | N-Acetyl-beta-D-mannosamine | 0.92 | Minutes | ST000047 | POSITIVE | Agilent 6220 TOF | Reversed phase | Human | Cerebrospinal fluid | |
AN000080 | SerSer | 0.92 | Minutes | ST000047 | POSITIVE | Agilent 6220 TOF | Reversed phase | Human | Cerebrospinal fluid | |
AN000080 | L-gamma-Cyano-gamma-aminobutyricacid | 0.92 | Minutes | ST000047 | POSITIVE | Agilent 6220 TOF | Reversed phase | Human | Cerebrospinal fluid | |
AN000080 | Acetoaceticacid | 0.93 | Minutes | ST000047 | POSITIVE | Agilent 6220 TOF | Reversed phase | Human | Cerebrospinal fluid | |
AN000080 | p-Aminobenzoicacid | 0.93 | Minutes | ST000047 | POSITIVE | Agilent 6220 TOF | Reversed phase | Human | Cerebrospinal fluid | |
AN000080 | alpha,alpha-Trehalose | 0.93 | Minutes | ST000047 | POSITIVE | Agilent 6220 TOF | Reversed phase | Human | Cerebrospinal fluid | |
AN000080 | AlaAlaAsp | 0.94 | Minutes | ST000047 | POSITIVE | Agilent 6220 TOF | Reversed phase | Human | Cerebrospinal fluid | |
AN000080 | 4-Aminobutyraldehyde | 0.94 | Minutes | ST000047 | POSITIVE | Agilent 6220 TOF | Reversed phase | Human | Cerebrospinal fluid | |
AN000080 | p-Aminobenzoicacid+0.94484663 | 0.94 | Minutes | ST000047 | POSITIVE | Agilent 6220 TOF | Reversed phase | Human | Cerebrospinal fluid | |
AN000080 | URETHANE | 0.95 | Minutes | ST000047 | POSITIVE | Agilent 6220 TOF | Reversed phase | Human | Cerebrospinal fluid | |
AN000080 | Creatine | 0.95 | Minutes | ST000047 | POSITIVE | Agilent 6220 TOF | Reversed phase | Human | Cerebrospinal fluid | |
AN000080 | 2-Aminopropanol | 0.95 | Minutes | ST000047 | POSITIVE | Agilent 6220 TOF | Reversed phase | Human | Cerebrospinal fluid | |
AN000080 | Diethanolamine | 0.96 | Minutes | ST000047 | POSITIVE | Agilent 6220 TOF | Reversed phase | Human | Cerebrospinal fluid | |
AN000080 | GlyValGly | 0.96 | Minutes | ST000047 | POSITIVE | Agilent 6220 TOF | Reversed phase | Human | Cerebrospinal fluid | |
AN000080 | Homoarginine | 0.96 | Minutes | ST000047 | POSITIVE | Agilent 6220 TOF | Reversed phase | Human | Cerebrospinal fluid | |
AN000080 | LysIle | 0.97 | Minutes | ST000047 | POSITIVE | Agilent 6220 TOF | Reversed phase | Human | Cerebrospinal fluid | |
AN000080 | Creatinine | 0.97 | Minutes | ST000047 | POSITIVE | Agilent 6220 TOF | Reversed phase | Human | Cerebrospinal fluid | |
AN000080 | Flucytosine | 0.98 | Minutes | ST000047 | POSITIVE | Agilent 6220 TOF | Reversed phase | Human | Cerebrospinal fluid | |
AN000080 | SerHisSer | 0.98 | Minutes | ST000047 | POSITIVE | Agilent 6220 TOF | Reversed phase | Human | Cerebrospinal fluid | |
AN000080 | GABOXADOL | 0.98 | Minutes | ST000047 | POSITIVE | Agilent 6220 TOF | Reversed phase | Human | Cerebrospinal fluid | |
AN000080 | 6-methyltetrahydropterin | 0.99 | Minutes | ST000047 | POSITIVE | Agilent 6220 TOF | Reversed phase | Human | Cerebrospinal fluid | |
AN000080 | LysGluVal | 0.99 | Minutes | ST000047 | POSITIVE | Agilent 6220 TOF | Reversed phase | Human | Cerebrospinal fluid | |
AN000080 | Flucytosine+0.99118036 | 0.99 | Minutes | ST000047 | POSITIVE | Agilent 6220 TOF | Reversed phase | Human | Cerebrospinal fluid | |
AN000080 | 2-Deoxyglucose | 0.99 | Minutes | ST000047 | POSITIVE | Agilent 6220 TOF | Reversed phase | Human | Cerebrospinal fluid | |
AN000080 | GlnSerThr | 1 | Minutes | ST000047 | POSITIVE | Agilent 6220 TOF | Reversed phase | Human | Cerebrospinal fluid | |
AN000080 | 5,6-Dihydrouridine | 1 | Minutes | ST000047 | POSITIVE | Agilent 6220 TOF | Reversed phase | Human | Cerebrospinal fluid | |
AN000080 | N-Acetyl-D-mannosamine | 1 | Minutes | ST000047 | POSITIVE | Agilent 6220 TOF | Reversed phase | Human | Cerebrospinal fluid | |
AN000080 | L-Alaninen-butylester | 1.01 | Minutes | ST000047 | POSITIVE | Agilent 6220 TOF | Reversed phase | Human | Cerebrospinal fluid | |
AN000080 | ISOLIQUIRITIGENIN | 1.02 | Minutes | ST000047 | POSITIVE | Agilent 6220 TOF | Reversed phase | Human | Cerebrospinal fluid | |
AN000080 | Triparanol+1.0181272 | 1.02 | Minutes | ST000047 | POSITIVE | Agilent 6220 TOF | Reversed phase | Human | Cerebrospinal fluid | |
AN000080 | ANETHOLE | 1.03 | Minutes | ST000047 | POSITIVE | Agilent 6220 TOF | Reversed phase | Human | Cerebrospinal fluid | |
AN000080 | Asymmetricdimethylarginine | 1.04 | Minutes | ST000047 | POSITIVE | Agilent 6220 TOF | Reversed phase | Human | Cerebrospinal fluid | |
AN000080 | 2-Hydroxyfelbamate | 1.04 | Minutes | ST000047 | POSITIVE | Agilent 6220 TOF | Reversed phase | Human | Cerebrospinal fluid | |
AN000080 | Homoserine | 1.04 | Minutes | ST000047 | POSITIVE | Agilent 6220 TOF | Reversed phase | Human | Cerebrospinal fluid | |
AN000080 | 2-Amino-3-methyl-1-butanol+1.045414 | 1.05 | Minutes | ST000047 | POSITIVE | Agilent 6220 TOF | Reversed phase | Human | Cerebrospinal fluid | |
AN000080 | N-Acetyl-L-Histidine | 1.05 | Minutes | ST000047 | POSITIVE | Agilent 6220 TOF | Reversed phase | Human | Cerebrospinal fluid | |
AN000080 | Niacinamide+1.0467085 | 1.05 | Minutes | ST000047 | POSITIVE | Agilent 6220 TOF | Reversed phase | Human | Cerebrospinal fluid | |
AN000080 | 2-Oxovalericacid+1.0467923 | 1.05 | Minutes | ST000047 | POSITIVE | Agilent 6220 TOF | Reversed phase | Human | Cerebrospinal fluid | |
AN000080 | Histidine+1.047004 | 1.05 | Minutes | ST000047 | POSITIVE | Agilent 6220 TOF | Reversed phase | Human | Cerebrospinal fluid | |
AN000080 | 2,4,6,8,10-dodecapentaenal | 1.05 | Minutes | ST000047 | POSITIVE | Agilent 6220 TOF | Reversed phase | Human | Cerebrospinal fluid | |
AN000080 | AlanineDimer | 1.05 | Minutes | ST000047 | POSITIVE | Agilent 6220 TOF | Reversed phase | Human | Cerebrospinal fluid | |
AN000080 | Dihydropteridine | 1.05 | Minutes | ST000047 | POSITIVE | Agilent 6220 TOF | Reversed phase | Human | Cerebrospinal fluid | |
AN000080 | GABOXADOL+1.0597433 | 1.06 | Minutes | ST000047 | POSITIVE | Agilent 6220 TOF | Reversed phase | Human | Cerebrospinal fluid | |
AN000080 | 5-(hydroxymethyl)-2-Furancarboxylicacid | 1.06 | Minutes | ST000047 | POSITIVE | Agilent 6220 TOF | Reversed phase | Human | Cerebrospinal fluid | |
AN000080 | Biotinamide | 1.09 | Minutes | ST000047 | POSITIVE | Agilent 6220 TOF | Reversed phase | Human | Cerebrospinal fluid | |
AN000080 | 4-(diaminomethylideneamino)butanoicacid | 1.09 | Minutes | ST000047 | POSITIVE | Agilent 6220 TOF | Reversed phase | Human | Cerebrospinal fluid | |
AN000080 | 3-O-Methyl-L-DOPA | 1.1 | Minutes | ST000047 | POSITIVE | Agilent 6220 TOF | Reversed phase | Human | Cerebrospinal fluid | |
AN000080 | Zalcitabine | 1.1 | Minutes | ST000047 | POSITIVE | Agilent 6220 TOF | Reversed phase | Human | Cerebrospinal fluid | |
AN000080 | DIBENZOTHIOPHENE | 1.1 | Minutes | ST000047 | POSITIVE | Agilent 6220 TOF | Reversed phase | Human | Cerebrospinal fluid | |
AN000080 | 4'-Hydroxyminoxidil | 1.1 | Minutes | ST000047 | POSITIVE | Agilent 6220 TOF | Reversed phase | Human | Cerebrospinal fluid | |
AN000080 | N-Acetyltranylcypromine | 1.1 | Minutes | ST000047 | POSITIVE | Agilent 6220 TOF | Reversed phase | Human | Cerebrospinal fluid | |
AN000080 | L-Serine | 1.11 | Minutes | ST000047 | POSITIVE | Agilent 6220 TOF | Reversed phase | Human | Cerebrospinal fluid | |
AN000080 | N2-Succinyl-L-ornithine | 1.12 | Minutes | ST000047 | POSITIVE | Agilent 6220 TOF | Reversed phase | Human | Cerebrospinal fluid | |
AN000080 | o-Hydroxyaniline | 1.14 | Minutes | ST000047 | POSITIVE | Agilent 6220 TOF | Reversed phase | Human | Cerebrospinal fluid | |
AN000080 | N-Acetylputrescine | 1.15 | Minutes | ST000047 | POSITIVE | Agilent 6220 TOF | Reversed phase | Human | Cerebrospinal fluid | |
AN000080 | Zalcitabine+1.1630843 | 1.16 | Minutes | ST000047 | POSITIVE | Agilent 6220 TOF | Reversed phase | Human | Cerebrospinal fluid | |
AN000080 | Urea+1.1698138 | 1.17 | Minutes | ST000047 | POSITIVE | Agilent 6220 TOF | Reversed phase | Human | Cerebrospinal fluid | |
AN000080 | S-(p-Azidophenacyl)glutathione | 1.18 | Minutes | ST000047 | POSITIVE | Agilent 6220 TOF | Reversed phase | Human | Cerebrospinal fluid | |
AN000080 | Valine+1.1798357 | 1.18 | Minutes | ST000047 | POSITIVE | Agilent 6220 TOF | Reversed phase | Human | Cerebrospinal fluid | |
AN000080 | Creatinine+1.1800067 | 1.18 | Minutes | ST000047 | POSITIVE | Agilent 6220 TOF | Reversed phase | Human | Cerebrospinal fluid | |
AN000080 | 5-(hydroxymethyl)-2-Furancarboxylicacid+1.1827083 | 1.18 | Minutes | ST000047 | POSITIVE | Agilent 6220 TOF | Reversed phase | Human | Cerebrospinal fluid | |
AN000080 | EthylOxalacetate | 1.2 | Minutes | ST000047 | POSITIVE | Agilent 6220 TOF | Reversed phase | Human | Cerebrospinal fluid | |
AN000080 | Ethambutolaldehyde | 1.2 | Minutes | ST000047 | POSITIVE | Agilent 6220 TOF | Reversed phase | Human | Cerebrospinal fluid | |
AN000080 | cyclohexylammonium | 1.21 | Minutes | ST000047 | POSITIVE | Agilent 6220 TOF | Reversed phase | Human | Cerebrospinal fluid | |
AN000080 | Glycine | 1.21 | Minutes | ST000047 | POSITIVE | Agilent 6220 TOF | Reversed phase | Human | Cerebrospinal fluid | |
AN000080 | Uridine | 1.22 | Minutes | ST000047 | POSITIVE | Agilent 6220 TOF | Reversed phase | Human | Cerebrospinal fluid | |
AN000080 | 5-aminosalicyluricacid | 1.22 | Minutes | ST000047 | POSITIVE | Agilent 6220 TOF | Reversed phase | Human | Cerebrospinal fluid | |
AN000080 | CysSer | 1.22 | Minutes | ST000047 | POSITIVE | Agilent 6220 TOF | Reversed phase | Human | Cerebrospinal fluid | |
AN000080 | 3,3,45-Tetrahydroxystilbene | 1.22 | Minutes | ST000047 | POSITIVE | Agilent 6220 TOF | Reversed phase | Human | Cerebrospinal fluid | |
AN000080 | 2-Furoicacid | 1.22 | Minutes | ST000047 | POSITIVE | Agilent 6220 TOF | Reversed phase | Human | Cerebrospinal fluid | |
AN000080 | AsnHisSer | 1.23 | Minutes | ST000047 | POSITIVE | Agilent 6220 TOF | Reversed phase | Human | Cerebrospinal fluid | |
AN000080 | DIBENZOTHIOPHENE+1.2266107 | 1.23 | Minutes | ST000047 | POSITIVE | Agilent 6220 TOF | Reversed phase | Human | Cerebrospinal fluid | |
AN000080 | 1-Aminocyclopropane-1-carboxylicacid+1.2266328 | 1.23 | Minutes | ST000047 | POSITIVE | Agilent 6220 TOF | Reversed phase | Human | Cerebrospinal fluid | |
AN000080 | 2,4,6,8,10-dodecapentaenal+1.227618 | 1.23 | Minutes | ST000047 | POSITIVE | Agilent 6220 TOF | Reversed phase | Human | Cerebrospinal fluid | |
AN000080 | TRANILAST | 1.23 | Minutes | ST000047 | POSITIVE | Agilent 6220 TOF | Reversed phase | Human | Cerebrospinal fluid | |
AN000080 | 8-Amino-7-oxononanoate | 1.23 | Minutes | ST000047 | POSITIVE | Agilent 6220 TOF | Reversed phase | Human | Cerebrospinal fluid | |
AN000080 | 5-Hydroxymethylcimetidine | 1.23 | Minutes | ST000047 | POSITIVE | Agilent 6220 TOF | Reversed phase | Human | Cerebrospinal fluid | |
AN000080 | Cytarabine | 1.23 | Minutes | ST000047 | POSITIVE | Agilent 6220 TOF | Reversed phase | Human | Cerebrospinal fluid | |
AN000080 | Cytosine | 1.23 | Minutes | ST000047 | POSITIVE | Agilent 6220 TOF | Reversed phase | Human | Cerebrospinal fluid | |
AN000080 | dimethylsulfoxide | 1.23 | Minutes | ST000047 | POSITIVE | Agilent 6220 TOF | Reversed phase | Human | Cerebrospinal fluid | |
AN000080 | 2,3-Dioxogulonicacid | 1.23 | Minutes | ST000047 | POSITIVE | Agilent 6220 TOF | Reversed phase | Human | Cerebrospinal fluid | |
AN000080 | trans-Aconitate | 1.23 | Minutes | ST000047 | POSITIVE | Agilent 6220 TOF | Reversed phase | Human | Cerebrospinal fluid | |
AN000080 | Furan2,5-dicarboxylicacid | 1.24 | Minutes | ST000047 | POSITIVE | Agilent 6220 TOF | Reversed phase | Human | Cerebrospinal fluid | |
AN000080 | 2-KetoglutaricAcid | 1.24 | Minutes | ST000047 | POSITIVE | Agilent 6220 TOF | Reversed phase | Human | Cerebrospinal fluid | |
AN000080 | 8-AminoCaprylicacid | 1.24 | Minutes | ST000047 | POSITIVE | Agilent 6220 TOF | Reversed phase | Human | Cerebrospinal fluid | |
AN000080 | DIALLYLSULFIDE | 1.24 | Minutes | ST000047 | POSITIVE | Agilent 6220 TOF | Reversed phase | Human | Cerebrospinal fluid | |
AN000080 | Triparanol+1.2402513 | 1.24 | Minutes | ST000047 | POSITIVE | Agilent 6220 TOF | Reversed phase | Human | Cerebrospinal fluid | |
AN000080 | Uricacid | 1.24 | Minutes | ST000047 | POSITIVE | Agilent 6220 TOF | Reversed phase | Human | Cerebrospinal fluid | |
AN000080 | 2-Methylindoline | 1.24 | Minutes | ST000047 | POSITIVE | Agilent 6220 TOF | Reversed phase | Human | Cerebrospinal fluid | |
AN000080 | (E)-2-Methylglutaconicacid+1.2437595 | 1.24 | Minutes | ST000047 | POSITIVE | Agilent 6220 TOF | Reversed phase | Human | Cerebrospinal fluid | |
AN000080 | Gamma-Glu-Leu | 1.24 | Minutes | ST000047 | POSITIVE | Agilent 6220 TOF | Reversed phase | Human | Cerebrospinal fluid | |
AN000080 | Bifemelane(M4) | 1.24 | Minutes | ST000047 | POSITIVE | Agilent 6220 TOF | Reversed phase | Human | Cerebrospinal fluid | |
AN000080 | Pyroglutamicacid+1.2445769 | 1.24 | Minutes | ST000047 | POSITIVE | Agilent 6220 TOF | Reversed phase | Human | Cerebrospinal fluid | |
AN000080 | AspAspPro | 1.24 | Minutes | ST000047 | POSITIVE | Agilent 6220 TOF | Reversed phase | Human | Cerebrospinal fluid | |
AN000080 | Carboxyprimaquine | 1.24 | Minutes | ST000047 | POSITIVE | Agilent 6220 TOF | Reversed phase | Human | Cerebrospinal fluid | |
AN000080 | Ecgonine | 1.25 | Minutes | ST000047 | POSITIVE | Agilent 6220 TOF | Reversed phase | Human | Cerebrospinal fluid | |
AN000080 | Tranexamicacid | 1.25 | Minutes | ST000047 | POSITIVE | Agilent 6220 TOF | Reversed phase | Human | Cerebrospinal fluid | |
AN000080 | Cephradine | 1.25 | Minutes | ST000047 | POSITIVE | Agilent 6220 TOF | Reversed phase | Human | Cerebrospinal fluid | |
AN000080 | Ethosuximide | 1.25 | Minutes | ST000047 | POSITIVE | Agilent 6220 TOF | Reversed phase | Human | Cerebrospinal fluid | |
AN000080 | D-Proline | 1.25 | Minutes | ST000047 | POSITIVE | Agilent 6220 TOF | Reversed phase | Human | Cerebrospinal fluid | |
AN000080 | Isopentenyladenine | 1.25 | Minutes | ST000047 | POSITIVE | Agilent 6220 TOF | Reversed phase | Human | Cerebrospinal fluid | |
AN000080 | Phenylalanine | 1.25 | Minutes | ST000047 | POSITIVE | Agilent 6220 TOF | Reversed phase | Human | Cerebrospinal fluid | |
AN000080 | 1-Methyladenosine | 1.25 | Minutes | ST000047 | POSITIVE | Agilent 6220 TOF | Reversed phase | Human | Cerebrospinal fluid | |
AN000080 | ProGluTyr | 1.25 | Minutes | ST000047 | POSITIVE | Agilent 6220 TOF | Reversed phase | Human | Cerebrospinal fluid | |
AN000080 | Acyclovir | 1.25 | Minutes | ST000047 | POSITIVE | Agilent 6220 TOF | Reversed phase | Human | Cerebrospinal fluid | |
AN000080 | Hypoxanthine | 1.25 | Minutes | ST000047 | POSITIVE | Agilent 6220 TOF | Reversed phase | Human | Cerebrospinal fluid | |
AN000080 | LeuPro | 1.25 | Minutes | ST000047 | POSITIVE | Agilent 6220 TOF | Reversed phase | Human | Cerebrospinal fluid | |
AN000080 | 2-Pyrrolidinone | 1.25 | Minutes | ST000047 | POSITIVE | Agilent 6220 TOF | Reversed phase | Human | Cerebrospinal fluid | |
AN000080 | AspLeu | 1.25 | Minutes | ST000047 | POSITIVE | Agilent 6220 TOF | Reversed phase | Human | Cerebrospinal fluid | |
AN000080 | Bis(2-hydroxypropyl)amine | 1.25 | Minutes | ST000047 | POSITIVE | Agilent 6220 TOF | Reversed phase | Human | Cerebrospinal fluid | |
AN000080 | 2-methylene-4-oxo-pentanedioicacid | 1.25 | Minutes | ST000047 | POSITIVE | Agilent 6220 TOF | Reversed phase | Human | Cerebrospinal fluid | |
AN000080 | 4-Hydroxy-L-threonine | 1.27 | Minutes | ST000047 | POSITIVE | Agilent 6220 TOF | Reversed phase | Human | Cerebrospinal fluid | |
AN000080 | 2-Butanone,4-[6-(sulfooxy)-2-naphthalenyl]- | 1.27 | Minutes | ST000047 | POSITIVE | Agilent 6220 TOF | Reversed phase | Human | Cerebrospinal fluid | |
AN000080 | 4-Hydroxypyridine | 1.3 | Minutes | ST000047 | POSITIVE | Agilent 6220 TOF | Reversed phase | Human | Cerebrospinal fluid | |
AN000080 | 4-Pyridoxicacid | 1.32 | Minutes | ST000047 | POSITIVE | Agilent 6220 TOF | Reversed phase | Human | Cerebrospinal fluid | |
AN000080 | D-Homoserine | 1.32 | Minutes | ST000047 | POSITIVE | Agilent 6220 TOF | Reversed phase | Human | Cerebrospinal fluid | |
AN000080 | GUVACINE | 1.34 | Minutes | ST000047 | POSITIVE | Agilent 6220 TOF | Reversed phase | Human | Cerebrospinal fluid | |
AN000080 | DIBENZOTHIOPHENE+1.3471979 | 1.35 | Minutes | ST000047 | POSITIVE | Agilent 6220 TOF | Reversed phase | Human | Cerebrospinal fluid | |
AN000080 | Methionine | 1.4 | Minutes | ST000047 | POSITIVE | Agilent 6220 TOF | Reversed phase | Human | Cerebrospinal fluid | |
AN000080 | Tyrosine | 1.47 | Minutes | ST000047 | POSITIVE | Agilent 6220 TOF | Reversed phase | Human | Cerebrospinal fluid | |
AN000080 | p-Coumaricacid | 1.47 | Minutes | ST000047 | POSITIVE | Agilent 6220 TOF | Reversed phase | Human | Cerebrospinal fluid | |
AN000080 | IleAla | 1.49 | Minutes | ST000047 | POSITIVE | Agilent 6220 TOF | Reversed phase | Human | Cerebrospinal fluid | |
AN000080 | L-Glutamicacidn-butylester | 1.5 | Minutes | ST000047 | POSITIVE | Agilent 6220 TOF | Reversed phase | Human | Cerebrospinal fluid | |
AN000080 | Pyroglutamicacid+1.5233006 | 1.52 | Minutes | ST000047 | POSITIVE | Agilent 6220 TOF | Reversed phase | Human | Cerebrospinal fluid | |
AN000080 | Hypoxanthine+1.5465705 | 1.55 | Minutes | ST000047 | POSITIVE | Agilent 6220 TOF | Reversed phase | Human | Cerebrospinal fluid | |
AN000080 | Aminosalicylicacid+1.590819 | 1.59 | Minutes | ST000047 | POSITIVE | Agilent 6220 TOF | Reversed phase | Human | Cerebrospinal fluid | |
AN000080 | Bis(2-hydroxypropyl)amine+1.6169006 | 1.62 | Minutes | ST000047 | POSITIVE | Agilent 6220 TOF | Reversed phase | Human | Cerebrospinal fluid | |
AN000080 | 2-Pyrrolidinone+1.6404546 | 1.64 | Minutes | ST000047 | POSITIVE | Agilent 6220 TOF | Reversed phase | Human | Cerebrospinal fluid | |
AN000080 | URETHANE+1.6414638 | 1.64 | Minutes | ST000047 | POSITIVE | Agilent 6220 TOF | Reversed phase | Human | Cerebrospinal fluid | |
AN000080 | Aminosalicylicacid+1.660612 | 1.66 | Minutes | ST000047 | POSITIVE | Agilent 6220 TOF | Reversed phase | Human | Cerebrospinal fluid | |
AN000080 | 4-Hydroxypyridine+1.6993763 | 1.7 | Minutes | ST000047 | POSITIVE | Agilent 6220 TOF | Reversed phase | Human | Cerebrospinal fluid | |
AN000080 | Aminosalicylicacid | 1.76 | Minutes | ST000047 | POSITIVE | Agilent 6220 TOF | Reversed phase | Human | Cerebrospinal fluid | |
AN000080 | 1-Methyladenosine+1.7661844 | 1.77 | Minutes | ST000047 | POSITIVE | Agilent 6220 TOF | Reversed phase | Human | Cerebrospinal fluid | |
AN000080 | Tyrosine+1.775995 | 1.78 | Minutes | ST000047 | POSITIVE | Agilent 6220 TOF | Reversed phase | Human | Cerebrospinal fluid | |
AN000080 | 3-(3-Indolyl)-2-oxopropanoicacid | 1.79 | Minutes | ST000047 | POSITIVE | Agilent 6220 TOF | Reversed phase | Human | Cerebrospinal fluid | |
AN000080 | p-Coumaricacid+1.7897145 | 1.79 | Minutes | ST000047 | POSITIVE | Agilent 6220 TOF | Reversed phase | Human | Cerebrospinal fluid | |
AN000080 | URETHANE+1.9081365 | 1.91 | Minutes | ST000047 | POSITIVE | Agilent 6220 TOF | Reversed phase | Human | Cerebrospinal fluid | |
AN000080 | 1-Methylguanine | 2.01 | Minutes | ST000047 | POSITIVE | Agilent 6220 TOF | Reversed phase | Human | Cerebrospinal fluid | |
AN000080 | Proline+2.0194335 | 2.02 | Minutes | ST000047 | POSITIVE | Agilent 6220 TOF | Reversed phase | Human | Cerebrospinal fluid | |
AN000080 | temazepam | 2.03 | Minutes | ST000047 | POSITIVE | Agilent 6220 TOF | Reversed phase | Human | Cerebrospinal fluid | |
AN000080 | Aminosalicylicacid+2.050458 | 2.05 | Minutes | ST000047 | POSITIVE | Agilent 6220 TOF | Reversed phase | Human | Cerebrospinal fluid | |
AN000080 | URETHANE+2.1131146 | 2.11 | Minutes | ST000047 | POSITIVE | Agilent 6220 TOF | Reversed phase | Human | Cerebrospinal fluid | |
AN000080 | Isoleucine | 2.18 | Minutes | ST000047 | POSITIVE | Agilent 6220 TOF | Reversed phase | Human | Cerebrospinal fluid | |
AN000080 | Proline+2.1935194 | 2.19 | Minutes | ST000047 | POSITIVE | Agilent 6220 TOF | Reversed phase | Human | Cerebrospinal fluid | |
AN000080 | GuanidinosuccinicAcid | 2.26 | Minutes | ST000047 | POSITIVE | Agilent 6220 TOF | Reversed phase | Human | Cerebrospinal fluid | |
AN000080 | Leucine | 2.26 | Minutes | ST000047 | POSITIVE | Agilent 6220 TOF | Reversed phase | Human | Cerebrospinal fluid | |
AN000080 | 2-Pyrrolidinone+2.5081131 | 2.51 | Minutes | ST000047 | POSITIVE | Agilent 6220 TOF | Reversed phase | Human | Cerebrospinal fluid | |
AN000080 | L-gamma-Cyano-gamma-aminobutyricacid+2.6655388 | 2.67 | Minutes | ST000047 | POSITIVE | Agilent 6220 TOF | Reversed phase | Human | Cerebrospinal fluid | |
AN000080 | N-Methyl-2-pyridone-5-carboxamide(Nudifloramide) | 2.73 | Minutes | ST000047 | POSITIVE | Agilent 6220 TOF | Reversed phase | Human | Cerebrospinal fluid | |
AN000080 | Homocysteine | 2.82 | Minutes | ST000047 | POSITIVE | Agilent 6220 TOF | Reversed phase | Human | Cerebrospinal fluid | |
AN000080 | N-Methyl-2-pyridone-5-carboxamide(Nudifloramide)+2.8463671 | 2.85 | Minutes | ST000047 | POSITIVE | Agilent 6220 TOF | Reversed phase | Human | Cerebrospinal fluid | |
AN000080 | 2-Pyrrolidinone+2.8932798 | 2.89 | Minutes | ST000047 | POSITIVE | Agilent 6220 TOF | Reversed phase | Human | Cerebrospinal fluid | |
AN000080 | Propionylglycinemethylester | 2.9 | Minutes | ST000047 | POSITIVE | Agilent 6220 TOF | Reversed phase | Human | Cerebrospinal fluid | |
AN000080 | Inosine+2.9386847 | 2.94 | Minutes | ST000047 | POSITIVE | Agilent 6220 TOF | Reversed phase | Human | Cerebrospinal fluid | |
AN000080 | Propionylglycinemethylester+2.9428074 | 2.94 | Minutes | ST000047 | POSITIVE | Agilent 6220 TOF | Reversed phase | Human | Cerebrospinal fluid | |
AN000080 | N-Methyl-2-pyridone-5-carboxamide(Nudifloramide)+2.9480572 | 2.95 | Minutes | ST000047 | POSITIVE | Agilent 6220 TOF | Reversed phase | Human | Cerebrospinal fluid | |
AN000080 | 2-Pyrrolidinone+2.9543996 | 2.95 | Minutes | ST000047 | POSITIVE | Agilent 6220 TOF | Reversed phase | Human | Cerebrospinal fluid | |
AN000080 | Inosine | 2.96 | Minutes | ST000047 | POSITIVE | Agilent 6220 TOF | Reversed phase | Human | Cerebrospinal fluid | |
AN000080 | Bis(2-hydroxypropyl)amine+2.961494 | 2.96 | Minutes | ST000047 | POSITIVE | Agilent 6220 TOF | Reversed phase | Human | Cerebrospinal fluid | |
AN000080 | Pyridoxine(VitaminB6) | 2.96 | Minutes | ST000047 | POSITIVE | Agilent 6220 TOF | Reversed phase | Human | Cerebrospinal fluid | |
AN000080 | 3-oxo-4-pentenoicacid+2.9779496 | 2.98 | Minutes | ST000047 | POSITIVE | Agilent 6220 TOF | Reversed phase | Human | Cerebrospinal fluid | |
AN000080 | Indospicine | 2.98 | Minutes | ST000047 | POSITIVE | Agilent 6220 TOF | Reversed phase | Human | Cerebrospinal fluid | |
AN000080 | 5-Ethyl-5-(1-methyl-3-carboxypropyl)barbituricacid | 3 | Minutes | ST000047 | POSITIVE | Agilent 6220 TOF | Reversed phase | Human | Cerebrospinal fluid | |
AN000080 | Chloramphenicolalcohol | 3.01 | Minutes | ST000047 | POSITIVE | Agilent 6220 TOF | Reversed phase | Human | Cerebrospinal fluid | |
AN000080 | 2-Methylbutyrylglycine | 3.01 | Minutes | ST000047 | POSITIVE | Agilent 6220 TOF | Reversed phase | Human | Cerebrospinal fluid | |
AN000080 | IlePro | 3.02 | Minutes | ST000047 | POSITIVE | Agilent 6220 TOF | Reversed phase | Human | Cerebrospinal fluid | |
AN000080 | 1-L-Leucyl-L-Proline | 3.05 | Minutes | ST000047 | POSITIVE | Agilent 6220 TOF | Reversed phase | Human | Cerebrospinal fluid | |
AN000080 | Ethosuximide+3.0564094 | 3.06 | Minutes | ST000047 | POSITIVE | Agilent 6220 TOF | Reversed phase | Human | Cerebrospinal fluid | |
AN000080 | IleAlaVal | 3.06 | Minutes | ST000047 | POSITIVE | Agilent 6220 TOF | Reversed phase | Human | Cerebrospinal fluid | |
AN000080 | 1-Methylguanosine | 3.08 | Minutes | ST000047 | POSITIVE | Agilent 6220 TOF | Reversed phase | Human | Cerebrospinal fluid | |
AN000080 | Acetoin | 3.09 | Minutes | ST000047 | POSITIVE | Agilent 6220 TOF | Reversed phase | Human | Cerebrospinal fluid | |
AN000080 | Pinacidil-N-Oxide | 3.1 | Minutes | ST000047 | POSITIVE | Agilent 6220 TOF | Reversed phase | Human | Cerebrospinal fluid | |
AN000080 | Valine+3.1044893 | 3.1 | Minutes | ST000047 | POSITIVE | Agilent 6220 TOF | Reversed phase | Human | Cerebrospinal fluid | |
AN000080 | 2-Amino-2-methyl-1-propanol | 3.11 | Minutes | ST000047 | POSITIVE | Agilent 6220 TOF | Reversed phase | Human | Cerebrospinal fluid | |
AN000080 | Phenylalanine+3.1124516 | 3.11 | Minutes | ST000047 | POSITIVE | Agilent 6220 TOF | Reversed phase | Human | Cerebrospinal fluid | |
AN000080 | 1-Methylinosine | 3.13 | Minutes | ST000047 | POSITIVE | Agilent 6220 TOF | Reversed phase | Human | Cerebrospinal fluid | |
AN000080 | Dihydromyricetin | 3.13 | Minutes | ST000047 | POSITIVE | Agilent 6220 TOF | Reversed phase | Human | Cerebrospinal fluid | |
AN000080 | beta-vinylacrylicacid+3.1429625 | 3.14 | Minutes | ST000047 | POSITIVE | Agilent 6220 TOF | Reversed phase | Human | Cerebrospinal fluid | |
AN000080 | Acetoin+3.1608412 | 3.16 | Minutes | ST000047 | POSITIVE | Agilent 6220 TOF | Reversed phase | Human | Cerebrospinal fluid | |
AN000080 | CARBADOX+3.2040133 | 3.2 | Minutes | ST000047 | POSITIVE | Agilent 6220 TOF | Reversed phase | Human | Cerebrospinal fluid | |
AN000080 | D-Leucicacid | 3.22 | Minutes | ST000047 | POSITIVE | Agilent 6220 TOF | Reversed phase | Human | Cerebrospinal fluid | |
AN000080 | D-Biotin | 3.22 | Minutes | ST000047 | POSITIVE | Agilent 6220 TOF | Reversed phase | Human | Cerebrospinal fluid | |
AN000080 | epinephrylborateopthalmicsolution | 3.22 | Minutes | ST000047 | POSITIVE | Agilent 6220 TOF | Reversed phase | Human | Cerebrospinal fluid | |
AN000080 | 3-Amino-2-piperidone | 3.24 | Minutes | ST000047 | POSITIVE | Agilent 6220 TOF | Reversed phase | Human | Cerebrospinal fluid | |
AN000080 | 1,3-Propanediamine | 3.24 | Minutes | ST000047 | POSITIVE | Agilent 6220 TOF | Reversed phase | Human | Cerebrospinal fluid | |
AN000080 | p-HYDROXYCINNAMALDEHYDE | 3.24 | Minutes | ST000047 | POSITIVE | Agilent 6220 TOF | Reversed phase | Human | Cerebrospinal fluid | |
AN000080 | 2,4-octadienal | 3.24 | Minutes | ST000047 | POSITIVE | Agilent 6220 TOF | Reversed phase | Human | Cerebrospinal fluid | |
AN000080 | pipecolicacid | 3.26 | Minutes | ST000047 | POSITIVE | Agilent 6220 TOF | Reversed phase | Human | Cerebrospinal fluid | |
AN000080 | 5-Hydroxytryptophan | 3.26 | Minutes | ST000047 | POSITIVE | Agilent 6220 TOF | Reversed phase | Human | Cerebrospinal fluid | |
AN000080 | Succinoadenosine | 3.26 | Minutes | ST000047 | POSITIVE | Agilent 6220 TOF | Reversed phase | Human | Cerebrospinal fluid | |
AN000080 | Phenylalanine+3.2762616 | 3.28 | Minutes | ST000047 | POSITIVE | Agilent 6220 TOF | Reversed phase | Human | Cerebrospinal fluid | |
AN000080 | Glutaral(Glutaraldehyde) | 3.28 | Minutes | ST000047 | POSITIVE | Agilent 6220 TOF | Reversed phase | Human | Cerebrospinal fluid | |
AN000080 | Pyridoxamine | 3.3 | Minutes | ST000047 | POSITIVE | Agilent 6220 TOF | Reversed phase | Human | Cerebrospinal fluid | |
AN000080 | 4-Amino-6,7-dimethoxy-2-(1-piperazinyl)quinazoline | 3.31 | Minutes | ST000047 | POSITIVE | Agilent 6220 TOF | Reversed phase | Human | Cerebrospinal fluid | |
AN000080 | D-Leucicacid+3.3511949 | 3.35 | Minutes | ST000047 | POSITIVE | Agilent 6220 TOF | Reversed phase | Human | Cerebrospinal fluid | |
AN000080 | Anthracene | 3.36 | Minutes | ST000047 | POSITIVE | Agilent 6220 TOF | Reversed phase | Human | Cerebrospinal fluid | |
AN000080 | Acetoin+3.357173 | 3.36 | Minutes | ST000047 | POSITIVE | Agilent 6220 TOF | Reversed phase | Human | Cerebrospinal fluid | |
AN000080 | LeuLeuAla | 3.38 | Minutes | ST000047 | POSITIVE | Agilent 6220 TOF | Reversed phase | Human | Cerebrospinal fluid | |
AN000080 | Leucine+3.3912697 | 3.39 | Minutes | ST000047 | POSITIVE | Agilent 6220 TOF | Reversed phase | Human | Cerebrospinal fluid | |
AN000080 | 2-Amino-2-methyl-1-propanol+3.3926477 | 3.39 | Minutes | ST000047 | POSITIVE | Agilent 6220 TOF | Reversed phase | Human | Cerebrospinal fluid | |
AN000080 | N2,N2-Dimethylguanosine | 3.4 | Minutes | ST000047 | POSITIVE | Agilent 6220 TOF | Reversed phase | Human | Cerebrospinal fluid | |
AN000080 | ROFECOXIB | 3.4 | Minutes | ST000047 | POSITIVE | Agilent 6220 TOF | Reversed phase | Human | Cerebrospinal fluid | |
AN000080 | D-Glucose | 3.4 | Minutes | ST000047 | POSITIVE | Agilent 6220 TOF | Reversed phase | Human | Cerebrospinal fluid | |
AN000080 | Isoniazid+3.4042652 | 3.4 | Minutes | ST000047 | POSITIVE | Agilent 6220 TOF | Reversed phase | Human | Cerebrospinal fluid | |
AN000080 | 4-Amino-6,7-dimethoxy-2-(1-piperazinyl)quinazoline+3.4088924 | 3.41 | Minutes | ST000047 | POSITIVE | Agilent 6220 TOF | Reversed phase | Human | Cerebrospinal fluid | |
AN000080 | 6,8-dihydroxy-octanoicacid | 3.41 | Minutes | ST000047 | POSITIVE | Agilent 6220 TOF | Reversed phase | Human | Cerebrospinal fluid | |
AN000080 | D-Leucicacid+3.4208822 | 3.42 | Minutes | ST000047 | POSITIVE | Agilent 6220 TOF | Reversed phase | Human | Cerebrospinal fluid | |
AN000080 | PantothenicAcid | 3.43 | Minutes | ST000047 | POSITIVE | Agilent 6220 TOF | Reversed phase | Human | Cerebrospinal fluid | |
AN000080 | Acetoin+3.4380774 | 3.44 | Minutes | ST000047 | POSITIVE | Agilent 6220 TOF | Reversed phase | Human | Cerebrospinal fluid | |
AN000080 | Benzylmalicacid | 3.47 | Minutes | ST000047 | POSITIVE | Agilent 6220 TOF | Reversed phase | Human | Cerebrospinal fluid | |
AN000080 | Triparanol+3.4729714 | 3.47 | Minutes | ST000047 | POSITIVE | Agilent 6220 TOF | Reversed phase | Human | Cerebrospinal fluid | |
AN000080 | Proline+3.5784535 | 3.58 | Minutes | ST000047 | POSITIVE | Agilent 6220 TOF | Reversed phase | Human | Cerebrospinal fluid | |
AN000080 | n-HexanoicAcid+3.6519935 | 3.65 | Minutes | ST000047 | POSITIVE | Agilent 6220 TOF | Reversed phase | Human | Cerebrospinal fluid | |
AN000080 | D-Leucicacid+3.683157 | 3.68 | Minutes | ST000047 | POSITIVE | Agilent 6220 TOF | Reversed phase | Human | Cerebrospinal fluid | |
AN000080 | Indoleacrylicacid | 3.69 | Minutes | ST000047 | POSITIVE | Agilent 6220 TOF | Reversed phase | Human | Cerebrospinal fluid | |
AN000080 | Phenytoin-N-glucuronide | 3.69 | Minutes | ST000047 | POSITIVE | Agilent 6220 TOF | Reversed phase | Human | Cerebrospinal fluid | |
AN000080 | ProHis | 3.69 | Minutes | ST000047 | POSITIVE | Agilent 6220 TOF | Reversed phase | Human | Cerebrospinal fluid | |
AN000080 | D-Glucose+3.6962345 | 3.7 | Minutes | ST000047 | POSITIVE | Agilent 6220 TOF | Reversed phase | Human | Cerebrospinal fluid | |
AN000080 | AsnGlySer | 3.72 | Minutes | ST000047 | POSITIVE | Agilent 6220 TOF | Reversed phase | Human | Cerebrospinal fluid | |
AN000080 | Acetoin+3.7338545 | 3.73 | Minutes | ST000047 | POSITIVE | Agilent 6220 TOF | Reversed phase | Human | Cerebrospinal fluid | |
AN000080 | 2-METHOXYRESORCINOL | 3.79 | Minutes | ST000047 | POSITIVE | Agilent 6220 TOF | Reversed phase | Human | Cerebrospinal fluid | |
AN000080 | Dacarbazine | 3.91 | Minutes | ST000047 | POSITIVE | Agilent 6220 TOF | Reversed phase | Human | Cerebrospinal fluid | |
AN000080 | Tetrahydrofuran | 3.92 | Minutes | ST000047 | POSITIVE | Agilent 6220 TOF | Reversed phase | Human | Cerebrospinal fluid | |
AN000080 | Acetoin+3.9354725 | 3.94 | Minutes | ST000047 | POSITIVE | Agilent 6220 TOF | Reversed phase | Human | Cerebrospinal fluid | |
AN000080 | 2-Methylbutyrylglycine+3.9581158 | 3.96 | Minutes | ST000047 | POSITIVE | Agilent 6220 TOF | Reversed phase | Human | Cerebrospinal fluid | |
AN000080 | Tranexamicacid+3.9845319 | 3.98 | Minutes | ST000047 | POSITIVE | Agilent 6220 TOF | Reversed phase | Human | Cerebrospinal fluid | |
AN000080 | D-Leucicacid+3.991298 | 3.99 | Minutes | ST000047 | POSITIVE | Agilent 6220 TOF | Reversed phase | Human | Cerebrospinal fluid | |
AN000080 | MYCOPHENOLICACID+4.000977 | 4 | Minutes | ST000047 | POSITIVE | Agilent 6220 TOF | Reversed phase | Human | Cerebrospinal fluid | |
AN000080 | Acetoin+4.037091 | 4.04 | Minutes | ST000047 | POSITIVE | Agilent 6220 TOF | Reversed phase | Human | Cerebrospinal fluid | |
AN000080 | 5-oxo-7-decynoicacid | 4.08 | Minutes | ST000047 | POSITIVE | Agilent 6220 TOF | Reversed phase | Human | Cerebrospinal fluid | |
AN000080 | 6-Formylindolo[3,2-B]carbazole | 4.11 | Minutes | ST000047 | POSITIVE | Agilent 6220 TOF | Reversed phase | Human | Cerebrospinal fluid | |
AN000080 | Indoleacrylicacid+4.1127377 | 4.11 | Minutes | ST000047 | POSITIVE | Agilent 6220 TOF | Reversed phase | Human | Cerebrospinal fluid | |
AN000080 | epsilon-Caprolactam | 4.12 | Minutes | ST000047 | POSITIVE | Agilent 6220 TOF | Reversed phase | Human | Cerebrospinal fluid | |
AN000080 | LysAsnPro | 4.2 | Minutes | ST000047 | POSITIVE | Agilent 6220 TOF | Reversed phase | Human | Cerebrospinal fluid | |
AN000080 | Caffeine | 4.21 | Minutes | ST000047 | POSITIVE | Agilent 6220 TOF | Reversed phase | Human | Cerebrospinal fluid | |
AN000080 | Isoniazid | 4.21 | Minutes | ST000047 | POSITIVE | Agilent 6220 TOF | Reversed phase | Human | Cerebrospinal fluid | |
AN000080 | GluGlu | 4.21 | Minutes | ST000047 | POSITIVE | Agilent 6220 TOF | Reversed phase | Human | Cerebrospinal fluid | |
AN000080 | 6,8-dihydroxy-octanoicacid+4.223625 | 4.22 | Minutes | ST000047 | POSITIVE | Agilent 6220 TOF | Reversed phase | Human | Cerebrospinal fluid | |
AN000080 | D-Leucicacid+4.228268 | 4.23 | Minutes | ST000047 | POSITIVE | Agilent 6220 TOF | Reversed phase | Human | Cerebrospinal fluid | |
AN000080 | Pinacidil | 4.32 | Minutes | ST000047 | POSITIVE | Agilent 6220 TOF | Reversed phase | Human | Cerebrospinal fluid | |
AN000080 | LysHis | 4.35 | Minutes | ST000047 | POSITIVE | Agilent 6220 TOF | Reversed phase | Human | Cerebrospinal fluid | |
AN000080 | N-gamma-Acetyl-N-2-formyl-5-methoxykynurenamine | 4.35 | Minutes | ST000047 | POSITIVE | Agilent 6220 TOF | Reversed phase | Human | Cerebrospinal fluid | |
AN000080 | Pinacidil+4.4089837 | 4.41 | Minutes | ST000047 | POSITIVE | Agilent 6220 TOF | Reversed phase | Human | Cerebrospinal fluid | |
AN000080 | ANISOMYCIN | 4.46 | Minutes | ST000047 | POSITIVE | Agilent 6220 TOF | Reversed phase | Human | Cerebrospinal fluid | |
AN000080 | 3-Hydroxycapricacid | 4.47 | Minutes | ST000047 | POSITIVE | Agilent 6220 TOF | Reversed phase | Human | Cerebrospinal fluid | |
AN000080 | 3-Hydroxycapricacid+4.517981 | 4.52 | Minutes | ST000047 | POSITIVE | Agilent 6220 TOF | Reversed phase | Human | Cerebrospinal fluid | |
AN000080 | ARECOLINE | 4.67 | Minutes | ST000047 | POSITIVE | Agilent 6220 TOF | Reversed phase | Human | Cerebrospinal fluid | |
AN000080 | Netilmicin | 4.75 | Minutes | ST000047 | POSITIVE | Agilent 6220 TOF | Reversed phase | Human | Cerebrospinal fluid | |
AN000080 | 8-Amino-7-oxononanoate+4.7958198 | 4.8 | Minutes | ST000047 | POSITIVE | Agilent 6220 TOF | Reversed phase | Human | Cerebrospinal fluid | |
AN000080 | GlnProLys | 4.83 | Minutes | ST000047 | POSITIVE | Agilent 6220 TOF | Reversed phase | Human | Cerebrospinal fluid | |
AN000080 | L-Glutamicaciddibutylester | 4.94 | Minutes | ST000047 | POSITIVE | Agilent 6220 TOF | Reversed phase | Human | Cerebrospinal fluid | |
AN000080 | Lidocaine | 4.97 | Minutes | ST000047 | POSITIVE | Agilent 6220 TOF | Reversed phase | Human | Cerebrospinal fluid | |
AN000080 | dihydro-alpha-ergocryptine | 5.04 | Minutes | ST000047 | POSITIVE | Agilent 6220 TOF | Reversed phase | Human | Cerebrospinal fluid | |
AN000080 | L-Glutamicaciddibutylester+5.1181326 | 5.12 | Minutes | ST000047 | POSITIVE | Agilent 6220 TOF | Reversed phase | Human | Cerebrospinal fluid | |
AN000080 | Benzenepropanoicacid,4-[2-hydroxy-3-[(1-methylethyl)amino]propoxy]-(9CI)ASL8123 | 5.12 | Minutes | ST000047 | POSITIVE | Agilent 6220 TOF | Reversed phase | Human | Cerebrospinal fluid | |
AN000080 | GlyValHis | 5.15 | Minutes | ST000047 | POSITIVE | Agilent 6220 TOF | Reversed phase | Human | Cerebrospinal fluid | |
AN000080 | L-Glutamicaciddibutylester+5.189158 | 5.19 | Minutes | ST000047 | POSITIVE | Agilent 6220 TOF | Reversed phase | Human | Cerebrospinal fluid | |
AN000080 | TyrPro | 5.2 | Minutes | ST000047 | POSITIVE | Agilent 6220 TOF | Reversed phase | Human | Cerebrospinal fluid | |
AN000080 | MYCOPHENOLICACID | 5.24 | Minutes | ST000047 | POSITIVE | Agilent 6220 TOF | Reversed phase | Human | Cerebrospinal fluid | |
AN000080 | bicyclo-PGE2 | 5.29 | Minutes | ST000047 | POSITIVE | Agilent 6220 TOF | Reversed phase | Human | Cerebrospinal fluid | |
AN000080 | L-Glutamicaciddibutylester+5.3399 | 5.34 | Minutes | ST000047 | POSITIVE | Agilent 6220 TOF | Reversed phase | Human | Cerebrospinal fluid | |
AN000080 | Limonene-1,2-epoxide | 5.35 | Minutes | ST000047 | POSITIVE | Agilent 6220 TOF | Reversed phase | Human | Cerebrospinal fluid | |
AN000080 | 3-Hydroxycapricacid+5.362054 | 5.36 | Minutes | ST000047 | POSITIVE | Agilent 6220 TOF | Reversed phase | Human | Cerebrospinal fluid | |
AN000080 | HisLeuSer | 5.39 | Minutes | ST000047 | POSITIVE | Agilent 6220 TOF | Reversed phase | Human | Cerebrospinal fluid | |
AN000080 | TRIACETIN | 5.43 | Minutes | ST000047 | POSITIVE | Agilent 6220 TOF | Reversed phase | Human | Cerebrospinal fluid | |
AN000080 | 8-Amino-7-oxononanoate+5.501855 | 5.5 | Minutes | ST000047 | POSITIVE | Agilent 6220 TOF | Reversed phase | Human | Cerebrospinal fluid | |
AN000080 | IdebenoneMetabolite(Benzenehexanoicacid,2,5-dihydroxy-3,4-dimethoxy-6-methyl-) | 5.67 | Minutes | ST000047 | POSITIVE | Agilent 6220 TOF | Reversed phase | Human | Cerebrospinal fluid | |
AN000080 | Mebeverine | 5.67 | Minutes | ST000047 | POSITIVE | Agilent 6220 TOF | Reversed phase | Human | Cerebrospinal fluid | |
AN000080 | 3alpha,6alpha,12alpha-Trihydroxy-7-oxo-5beta-cholan-24-oicAcid | 5.67 | Minutes | ST000047 | POSITIVE | Agilent 6220 TOF | Reversed phase | Human | Cerebrospinal fluid | |
AN000080 | MYCOPHENOLICACID+5.6754255 | 5.68 | Minutes | ST000047 | POSITIVE | Agilent 6220 TOF | Reversed phase | Human | Cerebrospinal fluid | |
AN000080 | IdebenoneMetabolite(Benzenehexanoicacid,2,5-dihydroxy-3,4-dimethoxy-6-methyl-)+5.7281647 | 5.73 | Minutes | ST000047 | POSITIVE | Agilent 6220 TOF | Reversed phase | Human | Cerebrospinal fluid | |
AN000080 | 7alpha-(Thiomethyl)spironolactone | 5.81 | Minutes | ST000047 | POSITIVE | Agilent 6220 TOF | Reversed phase | Human | Cerebrospinal fluid | |
AN000080 | IdebenoneMetabolite(Benzenehexanoicacid,2,5-dihydroxy-3,4-dimethoxy-6-methyl-)+5.8371787 | 5.84 | Minutes | ST000047 | POSITIVE | Agilent 6220 TOF | Reversed phase | Human | Cerebrospinal fluid | |
AN000080 | MYCOPHENOLICACID+5.9322114 | 5.93 | Minutes | ST000047 | POSITIVE | Agilent 6220 TOF | Reversed phase | Human | Cerebrospinal fluid | |
AN000080 | Carteolol | 6.19 | Minutes | ST000047 | POSITIVE | Agilent 6220 TOF | Reversed phase | Human | Cerebrospinal fluid | |
AN000080 | p-HYDROXYCINNAMALDEHYDE+6.348544 | 6.35 | Minutes | ST000047 | POSITIVE | Agilent 6220 TOF | Reversed phase | Human | Cerebrospinal fluid | |
AN000080 | 3-(2,5-dimethoxyphenyl)propanoicacid | 6.35 | Minutes | ST000047 | POSITIVE | Agilent 6220 TOF | Reversed phase | Human | Cerebrospinal fluid | |
AN000080 | LeuHisLeu | 6.49 | Minutes | ST000047 | POSITIVE | Agilent 6220 TOF | Reversed phase | Human | Cerebrospinal fluid | |
AN000080 | ValLysTyr | 6.61 | Minutes | ST000047 | POSITIVE | Agilent 6220 TOF | Reversed phase | Human | Cerebrospinal fluid | |
AN000080 | N-AcetylCilastatin | 6.69 | Minutes | ST000047 | POSITIVE | Agilent 6220 TOF | Reversed phase | Human | Cerebrospinal fluid | |
AN000080 | N-methyl-Gabapentin | 6.78 | Minutes | ST000047 | POSITIVE | Agilent 6220 TOF | Reversed phase | Human | Cerebrospinal fluid | |
AN000080 | Nadolol | 6.8 | Minutes | ST000047 | POSITIVE | Agilent 6220 TOF | Reversed phase | Human | Cerebrospinal fluid | |
AN000080 | 12-amino-dodecanoicacid | 6.94 | Minutes | ST000047 | POSITIVE | Agilent 6220 TOF | Reversed phase | Human | Cerebrospinal fluid | |
AN000080 | 5,7-nonadienoicacid | 7.3 | Minutes | ST000047 | POSITIVE | Agilent 6220 TOF | Reversed phase | Human | Cerebrospinal fluid | |
AN000080 | Penbutolol | 7.37 | Minutes | ST000047 | POSITIVE | Agilent 6220 TOF | Reversed phase | Human | Cerebrospinal fluid | |
AN000080 | 3'-Hydroxytrimethoprim | 7.44 | Minutes | ST000047 | POSITIVE | Agilent 6220 TOF | Reversed phase | Human | Cerebrospinal fluid | |
AN000080 | ISOSAFROLE | 7.74 | Minutes | ST000047 | POSITIVE | Agilent 6220 TOF | Reversed phase | Human | Cerebrospinal fluid | |
AN000080 | DIHYDROSPATHELIACHROMENE | 7.75 | Minutes | ST000047 | POSITIVE | Agilent 6220 TOF | Reversed phase | Human | Cerebrospinal fluid | |
AN000080 | ISOSAFROLE+7.781458 | 7.78 | Minutes | ST000047 | POSITIVE | Agilent 6220 TOF | Reversed phase | Human | Cerebrospinal fluid | |
AN000080 | PEUCENIN | 7.81 | Minutes | ST000047 | POSITIVE | Agilent 6220 TOF | Reversed phase | Human | Cerebrospinal fluid | |
AN000080 | PEUCENIN+7.86186 | 7.86 | Minutes | ST000047 | POSITIVE | Agilent 6220 TOF | Reversed phase | Human | Cerebrospinal fluid | |
AN000080 | ISOSAFROLE+7.876791 | 7.88 | Minutes | ST000047 | POSITIVE | Agilent 6220 TOF | Reversed phase | Human | Cerebrospinal fluid | |
AN000080 | n-HexanoicAcid | 7.89 | Minutes | ST000047 | POSITIVE | Agilent 6220 TOF | Reversed phase | Human | Cerebrospinal fluid | |
AN000080 | diethyltoluamide | 8.18 | Minutes | ST000047 | POSITIVE | Agilent 6220 TOF | Reversed phase | Human | Cerebrospinal fluid | |
AN000080 | Desmethyldoxepine | 8.19 | Minutes | ST000047 | POSITIVE | Agilent 6220 TOF | Reversed phase | Human | Cerebrospinal fluid | |
AN000080 | 3E,5E-tridecadienoicacid | 8.26 | Minutes | ST000047 | POSITIVE | Agilent 6220 TOF | Reversed phase | Human | Cerebrospinal fluid | |
AN000080 | 1-Hexadecylamine | 8.26 | Minutes | ST000047 | POSITIVE | Agilent 6220 TOF | Reversed phase | Human | Cerebrospinal fluid | |
AN000080 | Meradimate | 8.26 | Minutes | ST000047 | POSITIVE | Agilent 6220 TOF | Reversed phase | Human | Cerebrospinal fluid | |
AN000080 | Pentazocinetransacid | 8.26 | Minutes | ST000047 | POSITIVE | Agilent 6220 TOF | Reversed phase | Human | Cerebrospinal fluid | |
AN000080 | CysProIle | 8.27 | Minutes | ST000047 | POSITIVE | Agilent 6220 TOF | Reversed phase | Human | Cerebrospinal fluid | |
AN000080 | Desmethyldoxepine+8.275158 | 8.28 | Minutes | ST000047 | POSITIVE | Agilent 6220 TOF | Reversed phase | Human | Cerebrospinal fluid | |
AN000080 | ALPRENOLOL | 8.33 | Minutes | ST000047 | POSITIVE | Agilent 6220 TOF | Reversed phase | Human | Cerebrospinal fluid | |
AN000080 | (2-Chlorophenyl)diphenylmethane | 8.36 | Minutes | ST000047 | POSITIVE | Agilent 6220 TOF | Reversed phase | Human | Cerebrospinal fluid | |
AN000080 | Methyljasmonate | 8.57 | Minutes | ST000047 | POSITIVE | Agilent 6220 TOF | Reversed phase | Human | Cerebrospinal fluid | |
AN000080 | TyrProArg | 8.75 | Minutes | ST000047 | POSITIVE | Agilent 6220 TOF | Reversed phase | Human | Cerebrospinal fluid | |
AN000080 | LysCysHis | 8.86 | Minutes | ST000047 | POSITIVE | Agilent 6220 TOF | Reversed phase | Human | Cerebrospinal fluid | |
AN000080 | (R)-(+)-Citronellal | 8.95 | Minutes | ST000047 | POSITIVE | Agilent 6220 TOF | Reversed phase | Human | Cerebrospinal fluid | |
AN000080 | VALERYLSALYCILATE | 8.96 | Minutes | ST000047 | POSITIVE | Agilent 6220 TOF | Reversed phase | Human | Cerebrospinal fluid | |
AN000080 | 10-hydroxy-8E-Decene-2,4,6-triynoicacid | 8.96 | Minutes | ST000047 | POSITIVE | Agilent 6220 TOF | Reversed phase | Human | Cerebrospinal fluid | |
AN000080 | GibberellinA9 | 8.98 | Minutes | ST000047 | POSITIVE | Agilent 6220 TOF | Reversed phase | Human | Cerebrospinal fluid | |
AN000080 | RETUSOQUINONE | 8.98 | Minutes | ST000047 | POSITIVE | Agilent 6220 TOF | Reversed phase | Human | Cerebrospinal fluid | |
AN000080 | 2-ISOPROPYL-3-METHOXYCINNAMICACID | 8.98 | Minutes | ST000047 | POSITIVE | Agilent 6220 TOF | Reversed phase | Human | Cerebrospinal fluid | |
AN000080 | ,4-Dihydroxyphenylpropionicacid | 8.98 | Minutes | ST000047 | POSITIVE | Agilent 6220 TOF | Reversed phase | Human | Cerebrospinal fluid | |
AN000080 | p-Coumaricacid+8.976108 | 8.98 | Minutes | ST000047 | POSITIVE | Agilent 6220 TOF | Reversed phase | Human | Cerebrospinal fluid | |
AN000080 | cyclandelate | 8.98 | Minutes | ST000047 | POSITIVE | Agilent 6220 TOF | Reversed phase | Human | Cerebrospinal fluid | |
AN000080 | MetHisLys | 9.01 | Minutes | ST000047 | POSITIVE | Agilent 6220 TOF | Reversed phase | Human | Cerebrospinal fluid | |
AN000080 | C17Sphinganine | 9.03 | Minutes | ST000047 | POSITIVE | Agilent 6220 TOF | Reversed phase | Human | Cerebrospinal fluid | |
AN000080 | methyl8-[2-(2-formyl-vinyl)-3-hydroxy-5-oxo-cyclopentyl]-octanoate | 9.17 | Minutes | ST000047 | POSITIVE | Agilent 6220 TOF | Reversed phase | Human | Cerebrospinal fluid | |
AN000080 | MetHisLys+9.225381 | 9.23 | Minutes | ST000047 | POSITIVE | Agilent 6220 TOF | Reversed phase | Human | Cerebrospinal fluid | |
AN000080 | ProPheArg | 9.26 | Minutes | ST000047 | POSITIVE | Agilent 6220 TOF | Reversed phase | Human | Cerebrospinal fluid | |
AN000080 | 12-oxo-10Z-dodecenoicacid | 9.34 | Minutes | ST000047 | POSITIVE | Agilent 6220 TOF | Reversed phase | Human | Cerebrospinal fluid | |
AN000080 | 1-Pyrrolidinepropanol,a-(4-hydroxycyclohexyl)-a-phenyl-,trans- | 9.39 | Minutes | ST000047 | POSITIVE | Agilent 6220 TOF | Reversed phase | Human | Cerebrospinal fluid | |
AN000080 | 9-dodecen-1-ol | 9.45 | Minutes | ST000047 | POSITIVE | Agilent 6220 TOF | Reversed phase | Human | Cerebrospinal fluid | |
AN000080 | Meradimate+9.5246935 | 9.52 | Minutes | ST000047 | POSITIVE | Agilent 6220 TOF | Reversed phase | Human | Cerebrospinal fluid | |
AN000080 | MetHisLys+9.580145 | 9.58 | Minutes | ST000047 | POSITIVE | Agilent 6220 TOF | Reversed phase | Human | Cerebrospinal fluid | |
AN000080 | Embelin | 9.59 | Minutes | ST000047 | POSITIVE | Agilent 6220 TOF | Reversed phase | Human | Cerebrospinal fluid | |
AN000080 | 3-O-Methyldobutamine | 9.59 | Minutes | ST000047 | POSITIVE | Agilent 6220 TOF | Reversed phase | Human | Cerebrospinal fluid | |
AN000080 | n-Pentadecylamine | 9.67 | Minutes | ST000047 | POSITIVE | Agilent 6220 TOF | Reversed phase | Human | Cerebrospinal fluid | |
AN000080 | 3-O-Methyldobutamine+9.681883 | 9.68 | Minutes | ST000047 | POSITIVE | Agilent 6220 TOF | Reversed phase | Human | Cerebrospinal fluid | |
AN000080 | Acetoin+9.702633 | 9.7 | Minutes | ST000047 | POSITIVE | Agilent 6220 TOF | Reversed phase | Human | Cerebrospinal fluid | |
AN000080 | MetHisLys+9.714662 | 9.71 | Minutes | ST000047 | POSITIVE | Agilent 6220 TOF | Reversed phase | Human | Cerebrospinal fluid | |
AN000080 | Meradimate+9.747628 | 9.75 | Minutes | ST000047 | POSITIVE | Agilent 6220 TOF | Reversed phase | Human | Cerebrospinal fluid | |
AN000080 | Ubiquinone | 9.83 | Minutes | ST000047 | POSITIVE | Agilent 6220 TOF | Reversed phase | Human | Cerebrospinal fluid | |
AN000080 | MetHisLys+9.8822365 | 9.88 | Minutes | ST000047 | POSITIVE | Agilent 6220 TOF | Reversed phase | Human | Cerebrospinal fluid | |
AN000080 | MetHisLys+9.901607 | 9.9 | Minutes | ST000047 | POSITIVE | Agilent 6220 TOF | Reversed phase | Human | Cerebrospinal fluid | |
AN000080 | 3-Methylamino-1,2-propandiol | 9.93 | Minutes | ST000047 | POSITIVE | Agilent 6220 TOF | Reversed phase | Human | Cerebrospinal fluid | |
AN000080 | CARBETAPENTANE | 9.93 | Minutes | ST000047 | POSITIVE | Agilent 6220 TOF | Reversed phase | Human | Cerebrospinal fluid | |
AN000080 | Norpropoxyphene | 9.93 | Minutes | ST000047 | POSITIVE | Agilent 6220 TOF | Reversed phase | Human | Cerebrospinal fluid | |
AN000080 | 1alpha-hydroxy-22-(3-hydroxyphenyl)-23,24,25,26,27-pentanorvitaminD3/1alpha-hydroxy-22-(3-hydroxy | 9.94 | Minutes | ST000047 | POSITIVE | Agilent 6220 TOF | Reversed phase | Human | Cerebrospinal fluid | |
AN000080 | LeuProPro | 9.94 | Minutes | ST000047 | POSITIVE | Agilent 6220 TOF | Reversed phase | Human | Cerebrospinal fluid | |
AN000080 | MetHisLys+10.030071 | 10.03 | Minutes | ST000047 | POSITIVE | Agilent 6220 TOF | Reversed phase | Human | Cerebrospinal fluid | |
AN000080 | dodecanamide | 10.05 | Minutes | ST000047 | POSITIVE | Agilent 6220 TOF | Reversed phase | Human | Cerebrospinal fluid | |
AN000080 | dodecanamide+10.117273 | 10.12 | Minutes | ST000047 | POSITIVE | Agilent 6220 TOF | Reversed phase | Human | Cerebrospinal fluid | |
AN000080 | 2-amino-tetradecanoicacid | 10.12 | Minutes | ST000047 | POSITIVE | Agilent 6220 TOF | Reversed phase | Human | Cerebrospinal fluid | |
AN000080 | Desmethylthioridazine | 10.16 | Minutes | ST000047 | POSITIVE | Agilent 6220 TOF | Reversed phase | Human | Cerebrospinal fluid | |
AN000080 | 7-hydroxy-10E,16-heptadecadien-8-ynoicacid | 10.24 | Minutes | ST000047 | POSITIVE | Agilent 6220 TOF | Reversed phase | Human | Cerebrospinal fluid | |
AN000080 | Desmethylthioridazine+10.251241 | 10.25 | Minutes | ST000047 | POSITIVE | Agilent 6220 TOF | Reversed phase | Human | Cerebrospinal fluid | |
AN000080 | 1-Hexadecylamine+10.330298 | 10.33 | Minutes | ST000047 | POSITIVE | Agilent 6220 TOF | Reversed phase | Human | Cerebrospinal fluid | |
AN000080 | 7-DEACETOXY-7-OXOKHIVORIN | 10.38 | Minutes | ST000047 | POSITIVE | Agilent 6220 TOF | Reversed phase | Human | Cerebrospinal fluid | |
AN000080 | dodecanamide+10.603764 | 10.6 | Minutes | ST000047 | POSITIVE | Agilent 6220 TOF | Reversed phase | Human | Cerebrospinal fluid | |
AN000080 | 9-lauroleicacid | 10.67 | Minutes | ST000047 | POSITIVE | Agilent 6220 TOF | Reversed phase | Human | Cerebrospinal fluid | |
AN000080 | GlnSerHis | 10.71 | Minutes | ST000047 | POSITIVE | Agilent 6220 TOF | Reversed phase | Human | Cerebrospinal fluid | |
AN000080 | Atenolol | 10.92 | Minutes | ST000047 | POSITIVE | Agilent 6220 TOF | Reversed phase | Human | Cerebrospinal fluid | |
AN000080 | 6,9-hexadecadienoicacid | 11 | Minutes | ST000047 | POSITIVE | Agilent 6220 TOF | Reversed phase | Human | Cerebrospinal fluid | |
AN000080 | avobenzone | 11.03 | Minutes | ST000047 | POSITIVE | Agilent 6220 TOF | Reversed phase | Human | Cerebrospinal fluid | |
AN000080 | Phenoperidine | 11.03 | Minutes | ST000047 | POSITIVE | Agilent 6220 TOF | Reversed phase | Human | Cerebrospinal fluid | |
AN000080 | Dihydrolevobunolol | 11.08 | Minutes | ST000047 | POSITIVE | Agilent 6220 TOF | Reversed phase | Human | Cerebrospinal fluid | |
AN000080 | 3-ketopalmiticacid | 11.1 | Minutes | ST000047 | POSITIVE | Agilent 6220 TOF | Reversed phase | Human | Cerebrospinal fluid | |
AN000080 | VitaminD3glucosiduronate | 11.1 | Minutes | ST000047 | POSITIVE | Agilent 6220 TOF | Reversed phase | Human | Cerebrospinal fluid | |
AN000080 | Fusidicacid | 11.15 | Minutes | ST000047 | POSITIVE | Agilent 6220 TOF | Reversed phase | Human | Cerebrospinal fluid | |
AN000080 | QH2 | 11.19 | Minutes | ST000047 | POSITIVE | Agilent 6220 TOF | Reversed phase | Human | Cerebrospinal fluid | |
AN000080 | C24:1-OHSulfatide | 11.19 | Minutes | ST000047 | POSITIVE | Agilent 6220 TOF | Reversed phase | Human | Cerebrospinal fluid | |
AN000080 | HECOGENINACETATE | 11.19 | Minutes | ST000047 | POSITIVE | Agilent 6220 TOF | Reversed phase | Human | Cerebrospinal fluid | |
AN000080 | ThrHisGln | 11.22 | Minutes | ST000047 | POSITIVE | Agilent 6220 TOF | Reversed phase | Human | Cerebrospinal fluid | |
AN000080 | (23R,25R)-25-hydroxyvitaminD326,23-lactone/(23R,25R)-25-hydroxycholecalciferol26,23-lactone | 11.23 | Minutes | ST000047 | POSITIVE | Agilent 6220 TOF | Reversed phase | Human | Cerebrospinal fluid | |
AN000080 | ISOSAFROLE+11.260149 | 11.26 | Minutes | ST000047 | POSITIVE | Agilent 6220 TOF | Reversed phase | Human | Cerebrospinal fluid | |
AN000080 | Oxybutynin | 11.28 | Minutes | ST000047 | POSITIVE | Agilent 6220 TOF | Reversed phase | Human | Cerebrospinal fluid | |
AN000080 | Acetyl-farnesyl-cysteine | 11.29 | Minutes | ST000047 | POSITIVE | Agilent 6220 TOF | Reversed phase | Human | Cerebrospinal fluid | |
AN000080 | Vigabatrin+11.291644 | 11.29 | Minutes | ST000047 | POSITIVE | Agilent 6220 TOF | Reversed phase | Human | Cerebrospinal fluid | |
AN000080 | ISOSAFROLE+11.294703 | 11.29 | Minutes | ST000047 | POSITIVE | Agilent 6220 TOF | Reversed phase | Human | Cerebrospinal fluid | |
AN000080 | cyclandelate+11.3055525 | 11.31 | Minutes | ST000047 | POSITIVE | Agilent 6220 TOF | Reversed phase | Human | Cerebrospinal fluid | |
AN000080 | 2-ISOPROPYL-3-METHOXYCINNAMICACID+11.305641 | 11.31 | Minutes | ST000047 | POSITIVE | Agilent 6220 TOF | Reversed phase | Human | Cerebrospinal fluid | |
AN000080 | ArgSerPro | 11.31 | Minutes | ST000047 | POSITIVE | Agilent 6220 TOF | Reversed phase | Human | Cerebrospinal fluid | |
AN000080 | RETUSOQUINONE+11.308531 | 11.31 | Minutes | ST000047 | POSITIVE | Agilent 6220 TOF | Reversed phase | Human | Cerebrospinal fluid | |
AN000080 | ProProPhe | 11.31 | Minutes | ST000047 | POSITIVE | Agilent 6220 TOF | Reversed phase | Human | Cerebrospinal fluid | |
AN000080 | 12-oxo-9-octadecynoicacid | 11.42 | Minutes | ST000047 | POSITIVE | Agilent 6220 TOF | Reversed phase | Human | Cerebrospinal fluid | |
AN000080 | 16,16-dimethyl-PGF2beta+11.429014 | 11.43 | Minutes | ST000047 | POSITIVE | Agilent 6220 TOF | Reversed phase | Human | Cerebrospinal fluid | |
AN000080 | PenicillinV | 11.46 | Minutes | ST000047 | POSITIVE | Agilent 6220 TOF | Reversed phase | Human | Cerebrospinal fluid | |
AN000080 | BENZYLBUTYLPHTHALATE | 11.46 | Minutes | ST000047 | POSITIVE | Agilent 6220 TOF | Reversed phase | Human | Cerebrospinal fluid | |
AN000080 | RETUSOQUINONE+11.520966 | 11.52 | Minutes | ST000047 | POSITIVE | Agilent 6220 TOF | Reversed phase | Human | Cerebrospinal fluid | |
AN000080 | 13S-hydroxy-9E,11Z-octadecadienoicacid | 11.62 | Minutes | ST000047 | POSITIVE | Agilent 6220 TOF | Reversed phase | Human | Cerebrospinal fluid | |
AN000080 | Zopiclone | 11.62 | Minutes | ST000047 | POSITIVE | Agilent 6220 TOF | Reversed phase | Human | Cerebrospinal fluid | |
AN000080 | PhthalicacidMono-2-ethylhexylEster | 11.62 | Minutes | ST000047 | POSITIVE | Agilent 6220 TOF | Reversed phase | Human | Cerebrospinal fluid | |
AN000080 | LEVULINICACID,3-BENZYLIDENYL-+11.658154 | 11.66 | Minutes | ST000047 | POSITIVE | Agilent 6220 TOF | Reversed phase | Human | Cerebrospinal fluid | |
AN000080 | LEVULINICACID,3-BENZYLIDENYL- | 11.68 | Minutes | ST000047 | POSITIVE | Agilent 6220 TOF | Reversed phase | Human | Cerebrospinal fluid | |
AN000080 | fluoxymesterone | 11.68 | Minutes | ST000047 | POSITIVE | Agilent 6220 TOF | Reversed phase | Human | Cerebrospinal fluid | |
AN000080 | PhthalicacidMono-2-ethylhexylEster+11.684327 | 11.68 | Minutes | ST000047 | POSITIVE | Agilent 6220 TOF | Reversed phase | Human | Cerebrospinal fluid | |
AN000080 | 13,14-dihydro-19(R)-hydroxyPGE1 | 11.77 | Minutes | ST000047 | POSITIVE | Agilent 6220 TOF | Reversed phase | Human | Cerebrospinal fluid | |
AN000080 | Docosanedioicacid | 11.85 | Minutes | ST000047 | POSITIVE | Agilent 6220 TOF | Reversed phase | Human | Cerebrospinal fluid | |
AN000080 | (1S,2S)-3-oxo-2-pentyl-cyclopentanebutanoicacid | 11.87 | Minutes | ST000047 | POSITIVE | Agilent 6220 TOF | Reversed phase | Human | Cerebrospinal fluid | |
AN000080 | 3-methyl-tetradecanedioicacid | 11.88 | Minutes | ST000047 | POSITIVE | Agilent 6220 TOF | Reversed phase | Human | Cerebrospinal fluid | |
AN000080 | 8R-hydroxy-9Z-octadecenoicacid | 11.89 | Minutes | ST000047 | POSITIVE | Agilent 6220 TOF | Reversed phase | Human | Cerebrospinal fluid | |
AN000080 | GPIns(16:0/18:1(9Z))+11.922863 | 11.92 | Minutes | ST000047 | POSITIVE | Agilent 6220 TOF | Reversed phase | Human | Cerebrospinal fluid | |
AN000080 | 13E,17-octadecadienoicacid | 11.93 | Minutes | ST000047 | POSITIVE | Agilent 6220 TOF | Reversed phase | Human | Cerebrospinal fluid | |
AN000080 | GPIns(16:0/18:1(9Z)) | 11.93 | Minutes | ST000047 | POSITIVE | Agilent 6220 TOF | Reversed phase | Human | Cerebrospinal fluid | |
AN000080 | GPEtn(18:1(11Z)/18:1(9Z))[U]+11.980686 | 11.98 | Minutes | ST000047 | POSITIVE | Agilent 6220 TOF | Reversed phase | Human | Cerebrospinal fluid | |
AN000080 | 13,14-dihydro-15-keto-PGF2alpha | 11.99 | Minutes | ST000047 | POSITIVE | Agilent 6220 TOF | Reversed phase | Human | Cerebrospinal fluid | |
AN000080 | 8R-hydroxy-9Z-octadecenoicacid+12.002578 | 12 | Minutes | ST000047 | POSITIVE | Agilent 6220 TOF | Reversed phase | Human | Cerebrospinal fluid | |
AN000080 | 4,12-dihydroxy-hexadecanoicacid | 12.01 | Minutes | ST000047 | POSITIVE | Agilent 6220 TOF | Reversed phase | Human | Cerebrospinal fluid | |
AN000080 | 13E,17-octadecadienoicacid+12.112559 | 12.11 | Minutes | ST000047 | POSITIVE | Agilent 6220 TOF | Reversed phase | Human | Cerebrospinal fluid | |
AN000080 | 8R-hydroxy-9Z-octadecenoicacid+12.146298 | 12.15 | Minutes | ST000047 | POSITIVE | Agilent 6220 TOF | Reversed phase | Human | Cerebrospinal fluid | |
AN000080 | 1-Hydroxytetrahydrocannabinol | 12.19 | Minutes | ST000047 | POSITIVE | Agilent 6220 TOF | Reversed phase | Human | Cerebrospinal fluid | |
AN000080 | 7,8-Didehydroastaxanthin | 12.24 | Minutes | ST000047 | POSITIVE | Agilent 6220 TOF | Reversed phase | Human | Cerebrospinal fluid | |
AN000080 | 8R-hydroxy-9Z-octadecenoicacid+12.259173 | 12.26 | Minutes | ST000047 | POSITIVE | Agilent 6220 TOF | Reversed phase | Human | Cerebrospinal fluid | |
AN000080 | 3alpha,7alpha,12alpha-Trihydroxy-24-methyl-5beta-cholest-23-en-26-oicacid | 12.35 | Minutes | ST000047 | POSITIVE | Agilent 6220 TOF | Reversed phase | Human | Cerebrospinal fluid | |
AN000080 | 13E,17-octadecadienoicacid+12.351626 | 12.35 | Minutes | ST000047 | POSITIVE | Agilent 6220 TOF | Reversed phase | Human | Cerebrospinal fluid | |
AN000080 | C22Sulfatide | 12.38 | Minutes | ST000047 | POSITIVE | Agilent 6220 TOF | Reversed phase | Human | Cerebrospinal fluid | |
AN000080 | 8R-hydroxy-9Z-octadecenoicacid+12.398762 | 12.4 | Minutes | ST000047 | POSITIVE | Agilent 6220 TOF | Reversed phase | Human | Cerebrospinal fluid | |
AN000080 | 1-heptadecanoyl-2-(5Z,8Z,11Z,14Z-eicosatetraenoyl)-sn-glycero-3-phospho-(1'-rac-glycerol) | 12.41 | Minutes | ST000047 | POSITIVE | Agilent 6220 TOF | Reversed phase | Human | Cerebrospinal fluid | |
AN000080 | methyl-10-hydroperoxy-8E,12Z,15Z-octadecatrienoate | 12.43 | Minutes | ST000047 | POSITIVE | Agilent 6220 TOF | Reversed phase | Human | Cerebrospinal fluid | |
AN000080 | 9-lauroleicacid+12.430359 | 12.43 | Minutes | ST000047 | POSITIVE | Agilent 6220 TOF | Reversed phase | Human | Cerebrospinal fluid | |
AN000080 | CerebrosideC | 12.45 | Minutes | ST000047 | POSITIVE | Agilent 6220 TOF | Reversed phase | Human | Cerebrospinal fluid | |
AN000080 | Quinestrol | 12.65 | Minutes | ST000047 | POSITIVE | Agilent 6220 TOF | Reversed phase | Human | Cerebrospinal fluid | |
AN000080 | (-)N-(1R-methyl-propyl)arachidonoylamine | 12.7 | Minutes | ST000047 | POSITIVE | Agilent 6220 TOF | Reversed phase | Human | Cerebrospinal fluid | |
AN000080 | N-(2-hydroxyethyl)icosanamide | 12.71 | Minutes | ST000047 | POSITIVE | Agilent 6220 TOF | Reversed phase | Human | Cerebrospinal fluid | |
AN000080 | PGE1alcohol | 12.73 | Minutes | ST000047 | POSITIVE | Agilent 6220 TOF | Reversed phase | Human | Cerebrospinal fluid | |
AN000080 | cis-11-Hexadecenal | 12.82 | Minutes | ST000047 | POSITIVE | Agilent 6220 TOF | Reversed phase | Human | Cerebrospinal fluid | |
AN000080 | avobenzone+13.0102 | 13.01 | Minutes | ST000047 | POSITIVE | Agilent 6220 TOF | Reversed phase | Human | Cerebrospinal fluid | |
AN000080 | Camptothecin | 13.01 | Minutes | ST000047 | POSITIVE | Agilent 6220 TOF | Reversed phase | Human | Cerebrospinal fluid | |
AN000080 | 16beta-Hydroxystanozolol | 13.05 | Minutes | ST000047 | POSITIVE | Agilent 6220 TOF | Reversed phase | Human | Cerebrospinal fluid | |
AN000080 | 5a-Tetrahydrocorticosterone | 13.07 | Minutes | ST000047 | POSITIVE | Agilent 6220 TOF | Reversed phase | Human | Cerebrospinal fluid | |
AN000080 | 1alpha,25-dihydroxy-2beta-(4-hydroxybutoxy)vitaminD3/1alpha,25-dihydroxy-2beta-(4-hydroxybutoxy)c+13.128956 | 13.13 | Minutes | ST000047 | POSITIVE | Agilent 6220 TOF | Reversed phase | Human | Cerebrospinal fluid | |
AN000080 | 1alpha,25-dihydroxy-2beta-(4-hydroxybutoxy)vitaminD3/1alpha,25-dihydroxy-2beta-(4-hydroxybutoxy)c | 13.13 | Minutes | ST000047 | POSITIVE | Agilent 6220 TOF | Reversed phase | Human | Cerebrospinal fluid | |
AN000080 | N-acetyl-LTE4 | 13.14 | Minutes | ST000047 | POSITIVE | Agilent 6220 TOF | Reversed phase | Human | Cerebrospinal fluid | |
AN000080 | Octocrylene | 13.14 | Minutes | ST000047 | POSITIVE | Agilent 6220 TOF | Reversed phase | Human | Cerebrospinal fluid | |
AN000080 | CysAlaGly | 13.14 | Minutes | ST000047 | POSITIVE | Agilent 6220 TOF | Reversed phase | Human | Cerebrospinal fluid | |
AN000080 | Diphenoxylicacid(DPA) | 13.14 | Minutes | ST000047 | POSITIVE | Agilent 6220 TOF | Reversed phase | Human | Cerebrospinal fluid | |
AN000080 | Sulfacetamide | 13.14 | Minutes | ST000047 | POSITIVE | Agilent 6220 TOF | Reversed phase | Human | Cerebrospinal fluid | |
AN000080 | 8S-hydroxy-2-Decene-4,6-diynoicacid | 13.16 | Minutes | ST000047 | POSITIVE | Agilent 6220 TOF | Reversed phase | Human | Cerebrospinal fluid | |
AN000080 | 8-hydroxy-17-octadecene-10,12-diynoicacid | 13.16 | Minutes | ST000047 | POSITIVE | Agilent 6220 TOF | Reversed phase | Human | Cerebrospinal fluid | |
AN000080 | 8-hydroxy-17-octadecene-10,12-diynoicacid+13.171953 | 13.17 | Minutes | ST000047 | POSITIVE | Agilent 6220 TOF | Reversed phase | Human | Cerebrospinal fluid | |
AN000080 | Demissidine | 13.2 | Minutes | ST000047 | POSITIVE | Agilent 6220 TOF | Reversed phase | Human | Cerebrospinal fluid | |
AN000080 | 7-palmitoleicacid | 13.26 | Minutes | ST000047 | POSITIVE | Agilent 6220 TOF | Reversed phase | Human | Cerebrospinal fluid | |
AN000080 | 1alpha,25-dihydroxy-26,27-dimethyl-24a-homo-22-oxavitaminD3/1alpha,25-dihydroxy-26,27-dimethyl-24 | 13.35 | Minutes | ST000047 | POSITIVE | Agilent 6220 TOF | Reversed phase | Human | Cerebrospinal fluid | |
AN000080 | 2-Pyrrolidinone,1-ethyl-4-[2-[(2-hydroxyethyl)amino]ethyl]-3,3-diphenyl-(7CI,8CI,9CI) | 13.39 | Minutes | ST000047 | POSITIVE | Agilent 6220 TOF | Reversed phase | Human | Cerebrospinal fluid | |
AN000080 | 9,13-dihydroxy-11-octadecenoicacid | 13.4 | Minutes | ST000047 | POSITIVE | Agilent 6220 TOF | Reversed phase | Human | Cerebrospinal fluid | |
AN000080 | (1S,2S)-3-oxo-2-pentyl-cyclopentanebutanoicacid+13.396578 | 13.4 | Minutes | ST000047 | POSITIVE | Agilent 6220 TOF | Reversed phase | Human | Cerebrospinal fluid | |
AN000080 | Oleamide | 13.43 | Minutes | ST000047 | POSITIVE | Agilent 6220 TOF | Reversed phase | Human | Cerebrospinal fluid | |
AN000080 | 1alpha,25-dihydroxy-26,27-dimethyl-24a-homo-22-oxavitaminD3/1alpha,25-dihydroxy-26,27-dimethyl-24+13.434656 | 13.43 | Minutes | ST000047 | POSITIVE | Agilent 6220 TOF | Reversed phase | Human | Cerebrospinal fluid | |
AN000080 | LysLysLys | 13.43 | Minutes | ST000047 | POSITIVE | Agilent 6220 TOF | Reversed phase | Human | Cerebrospinal fluid | |
AN000080 | 2-decylenicacid | 13.44 | Minutes | ST000047 | POSITIVE | Agilent 6220 TOF | Reversed phase | Human | Cerebrospinal fluid | |
AN000080 | Perindopril+13.513286 | 13.51 | Minutes | ST000047 | POSITIVE | Agilent 6220 TOF | Reversed phase | Human | Cerebrospinal fluid | |
AN000080 | Perindopril | 13.6 | Minutes | ST000047 | POSITIVE | Agilent 6220 TOF | Reversed phase | Human | Cerebrospinal fluid | |
AN000080 | 1-hexadecanoyl-sn-glycerol | 13.6 | Minutes | ST000047 | POSITIVE | Agilent 6220 TOF | Reversed phase | Human | Cerebrospinal fluid | |
AN000080 | (5Z)-(3S)-1alpha,25-dihydroxy-3-deoxy-3-thiavitaminD33-oxide/(5Z)-(3S)-1alpha,25-dihydroxy-3-deo | 13.61 | Minutes | ST000047 | POSITIVE | Agilent 6220 TOF | Reversed phase | Human | Cerebrospinal fluid | |
AN000080 | ResolvinD1 | 13.62 | Minutes | ST000047 | POSITIVE | Agilent 6220 TOF | Reversed phase | Human | Cerebrospinal fluid | |
AN000080 | 2R-aminohexadecanoicacid | 13.63 | Minutes | ST000047 | POSITIVE | Agilent 6220 TOF | Reversed phase | Human | Cerebrospinal fluid | |
AN000080 | (24S)-1alpha,24,25-trihydroxy-22-oxavitaminD3/(24S)-1alpha,24,25-trihydroxy-22-oxacholecalciferol | 13.65 | Minutes | ST000047 | POSITIVE | Agilent 6220 TOF | Reversed phase | Human | Cerebrospinal fluid | |
AN000080 | Cholest-5-ene | 13.77 | Minutes | ST000047 | POSITIVE | Agilent 6220 TOF | Reversed phase | Human | Cerebrospinal fluid | |
AN000080 | N-(2-hydroxyethyl)stearamide | 13.99 | Minutes | ST000047 | POSITIVE | Agilent 6220 TOF | Reversed phase | Human | Cerebrospinal fluid | |
AN000080 | (6RS)-22-oxo-23,24,25,26,27-pentanorvitaminD36,19-sulfurdioxideadduct/(6RS)-22-oxo-23,24,25,26 | 14.08 | Minutes | ST000047 | POSITIVE | Agilent 6220 TOF | Reversed phase | Human | Cerebrospinal fluid | |
AN000080 | TG(16:1(9Z)/20:0/22:3(10Z,13Z,16Z))[iso6] | 14.11 | Minutes | ST000047 | POSITIVE | Agilent 6220 TOF | Reversed phase | Human | Cerebrospinal fluid | |
AN000080 | 8,13-dihydroxy-9,11-octadecadienoicacid | 14.14 | Minutes | ST000047 | POSITIVE | Agilent 6220 TOF | Reversed phase | Human | Cerebrospinal fluid | |
AN000080 | (24S)-1alpha,24-dihydroxy-22-oxavitaminD3/(24S)-1alpha,24-dihydroxy-22-oxacholecalciferol | 14.14 | Minutes | ST000047 | POSITIVE | Agilent 6220 TOF | Reversed phase | Human | Cerebrospinal fluid | |
AN000080 | C16Sphinganine | 14.14 | Minutes | ST000047 | POSITIVE | Agilent 6220 TOF | Reversed phase | Human | Cerebrospinal fluid | |
AN000080 | 9,12,14-octadecatrienoicacid | 14.14 | Minutes | ST000047 | POSITIVE | Agilent 6220 TOF | Reversed phase | Human | Cerebrospinal fluid | |
AN000080 | LeuProIle | 14.14 | Minutes | ST000047 | POSITIVE | Agilent 6220 TOF | Reversed phase | Human | Cerebrospinal fluid | |
AN000080 | 3-DeoxyvitaminD3 | 14.14 | Minutes | ST000047 | POSITIVE | Agilent 6220 TOF | Reversed phase | Human | Cerebrospinal fluid | |
AN000080 | 1-dodecanoyl-2-hexadecanoyl-3-octadecanoyl-sn-glycerol | 14.14 | Minutes | ST000047 | POSITIVE | Agilent 6220 TOF | Reversed phase | Human | Cerebrospinal fluid | |
AN000080 | octadecanamide | 14.14 | Minutes | ST000047 | POSITIVE | Agilent 6220 TOF | Reversed phase | Human | Cerebrospinal fluid | |
AN000080 | 1,2-di-(9Z,12Z-heptadecadienoyl)-3-octadecanoyl-sn-glycerol | 14.14 | Minutes | ST000047 | POSITIVE | Agilent 6220 TOF | Reversed phase | Human | Cerebrospinal fluid | |
AN000080 | Doxapram | 14.15 | Minutes | ST000047 | POSITIVE | Agilent 6220 TOF | Reversed phase | Human | Cerebrospinal fluid | |
AN000080 | 1a,1b-dihomo-15-deoxy-delta-12,14-PGD2 | 14.22 | Minutes | ST000047 | POSITIVE | Agilent 6220 TOF | Reversed phase | Human | Cerebrospinal fluid | |
AN000080 | 1a,1b-dihomo-15-deoxy-delta-12,14-PGD2+14.23761 | 14.24 | Minutes | ST000047 | POSITIVE | Agilent 6220 TOF | Reversed phase | Human | Cerebrospinal fluid | |
AN000080 | N-(2-hydroxyethyl)oleamide | 14.28 | Minutes | ST000047 | POSITIVE | Agilent 6220 TOF | Reversed phase | Human | Cerebrospinal fluid | |
AN000080 | 1beta,25-dihydroxy-2beta-(3-hydroxypropoxy)vitaminD3/1beta,25-dihydroxy-2beta-(3-hydroxypropoxy)c | 14.54 | Minutes | ST000047 | POSITIVE | Agilent 6220 TOF | Reversed phase | Human | Cerebrospinal fluid | |
AN000080 | 1alpha,25-dihydroxy-11beta-methoxyvitaminD3/1alpha,25-dihydroxy-11beta-methoxycholecalciferol | 14.62 | Minutes | ST000047 | POSITIVE | Agilent 6220 TOF | Reversed phase | Human | Cerebrospinal fluid | |
AN000080 | 1-octadecanoyl-rac-glycerol | 14.66 | Minutes | ST000047 | POSITIVE | Agilent 6220 TOF | Reversed phase | Human | Cerebrospinal fluid | |
AN000080 | ESTRADIOLCYPIONATE | 14.66 | Minutes | ST000047 | POSITIVE | Agilent 6220 TOF | Reversed phase | Human | Cerebrospinal fluid |